Peter Barany

Publications
CV
Public outreach and news

Articles

Article: TOXINS. 2025;17(12):592
Correlations Between Trimethylamine-N-Oxide, Megalin, Lysine and Markers of Tubular Damage in Chronic Kidney Disease
Kapetanaki S; Salihovic S; Kumawat AK; Massy ZA; Persson K; Barany P; Stenvinkel P; Evans M; Demirel I
Article: KIDNEY INTERNATIONAL. 2025;:S0085-2538(25)00883-X
A national cohort study examined the risk of severe infection and infection-related mortality in patients with chronic kidney disease with lupus nephritis in comparison to other chronic kidney disease etiologies.
Chrysostomou C; Faustini F; Segelmark M; Carrero J-J; Gunnarsson I; Barany P; Evans M; Faucon A-L
Article: CLINICAL KIDNEY JOURNAL. 2025;18(11):sfaf296
Applicability of the Framingham Risk Score in predicting mortality among kidney failure patients: an international analysis
Chen Z; Li X; Qureshi AR; Wang R; Jiang H; Heimburger O; Barany P; Chen J; Stenvinkel P; Lindholm B
Article: JOURNAL OF CLINICAL MEDICINE. 2025;14(21):7577
Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney Disease
Jankowska M; Qureshi AR; Haarhaus M; Magnusson P; Debska-Slizien A; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025;36(12):2392-2409
Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy
Levin A; Schwarz A; van Hoef V; Wijkstrom J; Bruchfeld A; Herthelius M; Wennberg L; Barany P; Witasp A; Wernerson A
Article: SCIENTIFIC REPORTS. 2025;15(1):2645
Association between extracellular DNA levels, markers of inflammation and left ventricular mass index in children with chronic kidney disease
Lindblad YT; Tothova L; Celec P; Kublickiene K; Barany P; Chromek M
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2025;85(1):45-54.e1
Burden of CKD-Associated Pruritus and Adverse Clinical Outcomes in Patients Receiving Dialysis: The Stockholm Creatinine Measurements (SCREAM) Project
Faucon A-L; Clase CM; Rydell H; Uhde M; Barany P; Evans M; Carrero J-J
Article: KIDNEY INTERNATIONAL REPORTS. 2025;10(1):157-168
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies
Chrysostomou C; Faustini F; Gunnarsson I; Segelmark M; Carrero J-J; Barany P; Faucon A-L; Evans M
Article: NUTRITION. 2024;125:112470
Handgrip strength and mortality in a cohort of kidney failure patients: Comparative analysis of different normalization methods
Suliman ME; Ryu K; Qureshi AR; Li X; Avesani CM; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: ESC HEART FAILURE. 2024;11(4):2334-2343
Heart failure: the grim reaper of the cardio-renal-metabolic triad
Osterman J; Al-Sodany E; Lofman IH; Barany P; Evans M
Article: LAKARTIDNINGEN. 2024;121:23214
SGLT2-hämmare – bra för hjärta och njurar men tänk på riskerna.
Nowinski K; Ugarph-Morawski A; Bárány P; Curman P
Article: CELLS. 2023;12(24):2774
Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation
Leotta C; Hernandez L; Tothova L; Arefin S; Ciceri P; Cozzolino MG; Barany P; Chromek M; Stenvinkel P; Kublickiene K
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2023;82(5):534-542
Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
Carrero J-J; Fu EL; Sang Y; Ballew S; Evans M; Elinder C-G; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(5):628-639
Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care
Xu Y; Evans M; Mazhar F; Arnlov J; Cockburn E; Barany P; Carrero J-J
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2023;34(7):1241-1251
Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations
Fu EL; Levey AS; Coresh J; Elinder C-G; Rotmans JI; Dekker FW; Paik JM; Barany P; Grams ME; Inker LA; Carrero J-J
Article: PEDIATRIC NEPHROLOGY. 2023;38(4):1205-1214
Kidney outcomes in early adolescence following perinatal asphyxia and hypothermia-treated hypoxic-ischaemic encephalopathy
Grossmann KR; Vishnevskaya L; Ruiz SD; Kublickiene K; Barany P; Blennow M; Chromek M
Article: JOURNAL OF NEPHROLOGY. 2023;36(3):705-711
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
Alkas J; Bosi A; Sjolander A; Barany P; Elinder C-G; Fu EL; Carrero JJ
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(7):6628
Blood-Brain Barrier Biomarkers before and after Kidney Transplantation
Hernandez L; Ward LJ; Arefin S; Barany P; Wennberg L; Soderberg M; Bruno S; Cantaluppi V; Stenvinkel P; Kublickiene K
Article: FRONTIERS IN NUTRITION. 2023;10:1035343
Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
Ryu K; Suliman ME; Qureshi AR; Chen Z; Avesani CM; Brismar TB; Ripsweden J; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: JOURNAL OF RENAL NUTRITION. 2023;33(2):298-306
Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients With Reduced Muscle Strength
Chen Z; Nilsson E; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR; Chen J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023;38(2):311-321
The role of dendrin in IgA nephropathy
Levin A; Schwarz A; Hulkko J; He L; Sun Y; Barany P; Bruchfeld A; Herthelius M; Wennberg L; Ebefors K; Patrakka J; Betsholtz C; Nystrom J; Molne J; Hultenby K; Witasp A; Wernerson A
Article: BMC NEPHROLOGY. 2023;24(1):20
The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease
Pistis KD; Westerberg P-A; Qureshi AR; Beshara S; Sterner G; Barany P; Linde T
Article: FRONTIERS IN ENDOCRINOLOGY. 2023;13:1046392
Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
Grigore TVV; Zuidscherwoude M; Witasp A; Barany P; Wernerson A; Bruchfeld A; Xu H; Olauson H; Hoenderop J
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2023;54(7-8):268-274
Interleukin-6 to albumin ratio as a superior predictor of mortality in end stage kidney disease patients
Li X; Qureshi AR; Suliman ME; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: PEDIATRIC NEPHROLOGY. 2022;37(12):3165-3175
Cardiac biomarkers in pediatric CKD-a prospective follow-up study
Lindblad YT; Vavilis G; Chromek M; Quershi AR; Lowbeer C; Barany P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(12):2474-2486
Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study
Verploegen MFA; Vargas-Poussou R; Walsh SB; Alpay H; Amouzegar A; Ariceta G; Atmis B; Bacchetta J; Barany P; Baron S; Bayrakci US; Belge H; Besouw M; Blanchard A; Bokenkamp A; Boyer O; Burgmaier K; Calo LA; Decramer S; Devuyst O; van Dyck M; Ferraro PM; Fila M; Francisco T; Ghiggeri GM; Gondra L; Guarino S; Hooman N; Hoorn EJ; Houillier P; Kamperis K; Kari JA; Konrad M; Levtchenko E; Lucchetti L; Lugani F; Marzuillo P; Mohidin B; Neuhaus TJ; Osman A; Papizh S; Perello M; Rookmaaker MB; Conti VS; Santos F; Sawaf G; Serdaroglu E; Szczepanska M; Taroni F; Topaloglu R; Trepiccione F; Vidal E; Wan ER; Weber L; Yildirim ZY; Yuksel S; Zlatanova G; Bockenhauer D; Emma F; Nijenhuis T
Article: LAKARTIDNINGEN. 2022;119:22017
[Janusmed Renal Function, an appreciated CDSS to support prescription of drugs and appropriate dosing in patients with renal impairment].
Justad H; Askfors Y; Shemeikka T; Rosenborg S; Veg A; Bárány P; Elinder C-G
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11S):246-247
Burden of Anemia in Patients With CKD Stages 3-5 Managed in Primary Care
Evans M; Xu Y; Mazhar F; Arnlov J; Cockburn E; Barany PF; Carrero JJ
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11S):231
Blood-Brain-Barrier Biomarkers in Patients Before and After Kidney Transplantation
Hernandez LN; Ward LJ; Arefin S; Barany PF
Article: JOURNAL OF HYPERTENSION. 2022;40(8):1487-1498
Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study
Al-Sodany E; Chesnaye NC; Heimburger O; Jager KJ; Barany P; Evans M
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2022;52(8):e13786
Angiotensin-converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end-stage kidney disease
Arefin S; Hernandez L; Ward LJ; Schwarz A; Barany P; Stenvinkel P; Kublickiene K
Article: SCIENTIFIC REPORTS. 2022;12(1):4414
Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
Hernandez L; Ward LJ; Arefin S; Ebert T; Laucyte-Cibulskiene A; Heimburger O; Barany P; Wennberg L; Stenvinkel P; Kublickiene K
Article: CLINICAL KIDNEY JOURNAL. 2022;15(3):442-451
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care
Bosi A; Xu Y; Gasparini A; Wettermark B; Barany P; Bellocco R; Inker LA; Chang AR; McAdams-DeMarco M; Grams ME; Shin J-I; Carrero JJ
Article: JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022;79(4):327-336
Association of Longitudinal High-Sensitivity Troponin T With Mortality in Patients With Chronic Kidney Disease
Chesnaye NC; Al-Sodany E; Szummer K; Barany P; Heimburger O; Almquist T; Melander S; Uhlin F; Dekker F; Wanner C; Jager KJ; Evans M
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2022;163:58-64
Epidemiology of Aortic Stenosis/Aortic Valve Replacement (from the Nationwide Swedish Renal Registry)
Vavilis G; Back M; Barany P; Szummer K
Article: SCIENTIFIC REPORTS. 2022;12(1):470
Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy
Witasp A; Luttropp K; Qureshi AR; Barany P; Heimburger O; Wennberg L; Ekstrom TJ; Shiels PG; Stenvinkel P; Nordfors L
Article: ACTA PAEDIATRICA. 2022;111(1):86-92
Acute kidney injury in infants with hypothermia-treated hypoxic-ischaemic encephalopathy: An observational population-based study
Grossmann KR; Barany P; Blennow M; Chromek M
Article: LAKARTIDNINGEN. 2021;118:21096
SGLT2-hämmare minskar risk för hjärt–kärl- och njursjukdom.
Nowinski K; Mannheimer B; Bárány P
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10S):188
Serum Erythroferrone and Serum Hepcidin 25 Are Associated with CKD
Pistis KD; Qureshi ART; Stenvinkel P; Lindholm B; Barany PF
Article: CLINICAL KIDNEY JOURNAL. 2021;14(10):2213-2220
Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease
Xu Y; Evans M; Soro M; Barany P; Carrero JJ
Article: CLINICAL KIDNEY JOURNAL. 2021;14(7):1789-1797
High-sensitivity troponins in dialysis patients: variation and prognostic value
Snaedal S; Barany P; Lund SH; Qureshi AR; Heimburger O; Stenvinkel P; Lowbeer C; Szummer K
Article: CLINICAL KIDNEY JOURNAL. 2021;14(7):1780-1788
Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study
Xu Y; Evans M; Barany P; James G; Sjolander A; Carrero JJ
Article: JOURNAL OF BONE AND MINERAL METABOLISM. 2021;39(2):260-269
Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality
Iseri K; Qureshi AR; Ripsweden J; Heimburger O; Barany P; Bergstrom IB; Stenvinkel P; Brismar TB; Lindholm B
Article: PLOS ONE. 2021;16(2):e0247623
Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study
Dai L; Li L; Erlandsson H; Jaminon AMG; Qureshi AR; Ripsweden J; Brismar TB; Witasp A; Heimburger O; Jorgensen HS; Barany P; Lindholm B; Evenepoel P; Schurgers LJ; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(12):2059-2072
Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium
Levin A; Reznichenko A; Witasp A; Liu P; Greasley PJ; Sorrentino A; Blondal T; Zambrano S; Nordstrom J; Bruchfeld A; Barany P; Ebefors K; Erlandsson F; Patrakka J; Stenvinkel P; Nystrom J; Wernerson A
Journal article: CIRCULATION. 2020;142
Risk Factors for New-onset Aortic Stenosis and Aortic Valve Replacement in End-Stage Renal Disease Patients - Results From the Swedish Renal Registry
Vavilis G; Back M; Barany P; Szummer K
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(11):1908-1915
Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project
Runesson B; Trevisan M; Iseri K; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
Journal article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2020;31(10S):362
Poor Vitamin K Status Associates with Worse Clinical Outcome Independent of Coronary Artery Calcium and Aortic Valve Calcium in ESRD
Dai L; Li L; Qureshi ART; Ripsweden J; Brismar TB; Heimburger O; Barany PF; Lindholm B; Schurgers LJ; Stenvinkel P
Article: CLINICAL KIDNEY JOURNAL. 2020;13(5):821-827
Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
Evans M; Bower H; Cockburn E; Jacobson SH; Barany P; Carrero J-J
Article: CLINICAL TRANSPLANTATION. 2020;34(10):e14063
Pediatric transplantation in Europe during the COVID-19 pandemic: Early impact on activity and healthcare
Dona D; Torres Canizales J; Benetti E; Cananzi M; De Corti F; Calore E; Hierro L; Ramos Boluda E; Melgosa Hijosa M; Garcia Guereta L; Perez Martinez A; Barrios M; Costa Reis P; Teixeira A; Lopes MF; Kalicinski P; Branchereau S; Boyer O; Debray D; Sciveres M; Wennberg L; Fischler B; Barany P; Baker A; Baumann U; Schwerk N; Nicastro E; Candusso M; Toporski J; Sokal E; Stephenne X; Lindemans C; Miglinas M; Rascon J; Jara P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(9):1518-1526
Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study
Laureati P; Xu Y; Trevisan M; Schalin L; Mariani I; Bellocco R; Sood MM; Barany P; Sjolander A; Evans M; Carrero JJ
Article: DIABETES OBESITY & METABOLISM. 2020;22(8):1425-1435
Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements (SCREAM) project
Runesson B; Xu Y; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(7):1202-1211
Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease
Mukai H; Dai L; Chen Z; Lindholm B; Ripsweden J; Brismar TB; Heimburger O; Barany P; Qureshi AR; Soderberg M; Back M; Stenvinkel P
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(4):422-434
Phenotypic features of vascular calcification in chronic kidney disease
Dai L; Debowska M; Lukaszuk T; Bobrowski L; Barany P; Soderberg M; Thiagarajan D; Frostegard J; Wennberg L; Lindholm B; Qureshi AR; Waniewski J; Stenvinkel P
Article: BMC NEPHROLOGY. 2020;21(1):43
Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5.
Golembiewska E; Qureshi AR; Dai L; Lindholm B; Heimbürger O; Söderberg M; Brismar TB; Ripsweden J; Barany P; Johnson RJ; Stenvinkel P
Article: BONE. 2020;130:115075
Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study
Iseri K; Qureshi AR; Dai L; Ripsweden J; Heimburger O; Barany P; Bergstrom I; Stenvinkel P; Brismar TB; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(12):2051-2057
Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease
Xu H; Hashem A; Witasp A; Mencke R; Goldsmith D; Barany P; Bruchfeld A; Wernerson A; Carrero J-J; Olauson H
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(21):e013091
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
Chesnaye NC; Szummer K; Barany P; Heimburger O; Magin H; Almquist T; Uhlin F; Dekker FW; Wanner C; Jager KJ; Evans M; Cupisti A; Sagliocca A; Ferraro A; Musiala A; Mele A; Naticchia A; Cosaro A; Woodman A; Ranghino A; Stucchi A; Jonsson A; Schneider A; Pignataro A; Schrander A; Torp A; McKeever A; Szymczak A; Blom A-L; De Blasio A; Pani A; Tsalouichos A; Ullah A; McLaren B; van Dam B; Iwig B; Antonio B; Di Iorio BR; Rogland B; Perras B; Alessandra B; Harron C; Wallquist C; Siegert C; Barrett C; Gaillard C; Abaterusso C; Beerenhout C; O'Toole C; Somma C; Marx C; Drechsler C; Summersgill C; Blaser C; D'alessandro C; Emde C; Torino C; Zullo C; Pozzi C; Geddes C; Verburgh C; Janmaat C; Bergamo D; Ciurlino D; Motta D; Glowski D; McGlynn D; Vargas D; Krieter D; Russo D; Fuchs D; Sands D; Hoogeveen E; Irmler E; Dimeny E; Favaro E; Platen E; Olczyk E; Hoorn E; Vigotti F; Caskey F; Ansali F; Conte F; Cianciotta F; Giacchino F; Cappellaio F; Pizzarelli F; Sundelin F; Greco G; Roy G; Porto G; Bigatti G; Marinangeli G; Cabiddu G; Hirst G; Fumagalli G; Caloro G; Piccoli G; Capasso G; Gambaro G; Tognarelli G; Bonforte G; Conte G; Toscano G; Del Rosso G; Welander G; Augustyniak-Bartosik H; Boots J; Schmidt-Gurtler H; King H; McNally H; Schlee H; Boom H; Naujoks H; Masri-Senghor H; Murtagh H; Rayner H; Miskowiec-Wisniewska I; Schlee I; Capizzi I; Casar S; Hernandez IB; Baragetti I; Manitius J; Turner J; Eijgenraam J-W; Kooman J; Beige J; Pondel J; Wilcox J; Berdeprado J; Rothele J; Wong J; Rotmans J; Banda J; Mazur J; Hahn K; Jezdrzejak K; Nowanska K; Blouin K; Neumeier K; Jones K; Anding-Rost K; Grontoft K-C; Oldrizzi L; Haydock L; Vogt L; Wilkinson L; Gesualdo L; Schramm L; Biancone L; Nowak L; Raasveld M; Szymczak M; Durlik M; Magnano M; Vervloet M; Ricardi M; Carmody M; Di Bari M; Laudato M; Sirico ML; Stendahl M; Svensson M; Weetman M; van Buren M; Joinson M; Ferraresi M; Dutton M; Postorino M; van Diepen M; Matthews M; Provenzano M; Hopf M; Malaguti M; Wuttke N; Morgan N; Palmieri N; Frischmuth N; Bleakley N; Murrone P; Cockwell P; Leurs P; Roderick P; Voskamp P; Kashioulis P; Ichtiaris P; Blankestijn P; Kirste P; Schulz P; Mason P; Kalra P; Cirillo P; Dattolo P; Acampora P; Sajith R; Nigro R; Boero R; Scarpioni R; Sicoli R; Malandra R; Aign S; van Esch S; Chapman S; Biribauer S; Navjee S; Crosbie S; Brown S; Tickle S; Manan S; Roser S; Savoldi S; Bertoli S; Borrelli S; Boorsma S; Heidenreich S; Melander S; Maxia S; Maffei S; Mangano S; Palm S; Konings C; Mathavakkannan S; Schwedler S; Delrieux S; Renker S; Schattel S; Dorota S; Cicchetti T; Nieszporek T; Stephan T; Schmiedeke T; Weinreich T; Leimbach T; Rappa T; Stovesand T; Bahner U; Jensen U; Palazzo V; De Simone W; Seeger W; Kuan Y; Heleniak Z; Aydin Z
Article: AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. 2019;317(5):F1122-F1131
Reduced skeletal muscle expression of mitochondrial-derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease
Liu C; Gidlund E-K; Witasp A; Qureshi AR; Soderberg M; Thorell A; Nader GA; Barany P; Stenvinkel P; von Walden F
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;68:60-65
Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease
Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimburger O; Barany P; Lindholm B; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(9):1534-1541
Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project
Gasparini A; Evans M; Barany P; Xu H; Jernberg T; Arnlov J; Lund LH; Carrero J-J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp411
FP411THE ASSOCIATION BETWEEN RENAL FUNCTION AND TROPONIN T OVER TIME IN STABLE CKD PATIENTS
Chesnaye N; Szummer K; Barany P; Heimburger O; Magin H; Uhlin F; Dekker FW; Wanner C; Jager K; Evans M
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp392
FP392DYNAMIC PREDICTION OF MORTALITY IN ADVANCED CKD USING TROPONIN T
Chesnaye N; Szummer K; Barany P; Heimburger O; Stenvinkel P; Melander S; Dekker FW; Wanner C; Jager K; Evans M
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz096.fo040
FO040Achieved blood pressure and outcomes in patients with advanced chronic kidney disease stage 4-5
Al-sodany E; Marie E; Olof H; Peter B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp361
FP361PREDICTORS OF VASCULAR CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS
Dai L; Debowska M; Lukaszuk T; Bobrowski L; Pietribiasi M; Barany P; Söderberg M; Wernerson A; Lindholm B; Qureshi AR; Waniewski J; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz096.fc020
FC020BONE MINERAL DENSITY AT VARIOUS SITES VERSUS MORTALITY IN END-STAGE RENAL DISEASE (ESRD)
Iseri K; Qureshi AR; Dai L; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz103.sp402
SP402PENTOSIDINE IN END-STAGE RENAL DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) VERSUS OTHER ETIOLOGIES
Jankowska M; Qureshi AR; Lu D; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp391
FP391FRACTURE RISK IN NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (CKD): INCIDENCE, PREDICTORS AND SEQUELAE
Runesson B; Trevisan M; Iseri K; Bengt L; Peter B; Elinder C-G; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp151
FP151SODIUM POLYSTYRENE SULFONATE, PRACTICE PATTERNS AND ASSOCIATED ADVERSE EVENT RISK; A NATIONWIDE ANALYSIS FROM THE SWEDISH RENAL REGISTER
Laureati P; Evans M; Trevisan M; Schalin L; Bellocco R; Sood MM; Barany P; Carrero JJ
Article: BMC NEPHROLOGY. 2019;20(1):144
Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
Pei M; Aguiar R; Pagels AA; Heimburger O; Stenvinkel P; Barany P; Medin C; Jacobson SH; Hylander B; Lindholm B; Qureshi AR
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(8):e010546
Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Mok Y; Ballew SH; Sang Y; Grams ME; Coresh J; Evans M; Barany P; Arnlov J; Carrero J-J; Matsushita K
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2019;14(4):530-539
Estimated Glomerular Filtration Rate and the Risk of Cancer
Xu H; Matsushita K; Su G; Trevisan M; Arnlov J; Barany P; Lindholm B; Elinder C-G; Lambe M; Carrero J-J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(3):442-448
Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study
Mukai H; Svedberg O; Lindholm B; Dai L; Heimbuerger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Article: BMC NEPHROLOGY. 2019;20(1):59
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
Chen Z; Qureshi AR; Brismar TB; Ripsweden J; Haarhaus M; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Article: JOURNAL OF NEPHROLOGY. 2019;32(1):111-119
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.
Feldreich T; Nowak C; Fall T; Carlsson AC; Carrero J-J; Ripsweden J; Qureshi AR; Heimbürger O; Barany P; Stenvinkel P; Vuilleumier N; Kalra PA; Green D; Ärnlöv J
Article: PLOS ONE. 2019;14(1):e0209440
Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project
Runesson B; Qureshi AR; Xu H; Gasparini A; Lindholm B; Barany P; Elinder CG; Carrero JJ
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2018;13(9):1314-1320
Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease The Stockholm CREAtinine Measurements (SCREAM) Project
Carrero JJ; Trevisan M; Sood MM; Barany P; Xu H; Evans M; Friberg L; Szummer K
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20(8):1217-1226
Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund LH; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i452
SP323HIGH FIBRINOGEN LEVELS ARE INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Hasbal NB; Mukai H; Chen Z; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i444
SP298HIGHER MEAN CORPUSCULAR VOLUME ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Lindholm B; Heimbürger O; Barany P; Qureshi AR; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i144-i145
FP336HIGHER NEUTROPHIL TO LYMPHOCYTE RATIO ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Kato S; Lindholm B; Heimbürger O; Barany P; Washida N; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i325
SaO024INCIDENCE, PREDICTORS AND CLINICAL MANAGEMENT OF HYPERKALEMIA IN NEW USERS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund L; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i455
SP330AEGFR AND THE RISK OF CANCER: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Xu H; Su G; Trevisan M; Elinder C-G; Barany P; Lindholm B; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i146
FP341PLASMA POTASSIUM AND THE RISK OF MORTALITY: A TIME-DEPENDENT ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Trevisan M; Evans M; Xu H; Lindholm B; Barany P; Elinder C-G; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33(suppl_1):i1
FO002FIBROBLAST GROWTH FACTOR 23 IS ASSOCIATED WITH FRACTIONAL SODIUM EXCRETION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Xu H; Hashem A; Witasp A; Mencke R; Stenvinkel P; Barany P; Bruchfeld A; Wernerson A; Carrero J-J; Olauson H
Article: EUROPEAN HEART JOURNAL. 2018;39(17):1535-1542
Serumpotassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortiummeta-analysis
Kovesdy CP; Matsushita K; Sang Y; Brunskill NJ; Carrero JJ; Chodick G; Hasegawa T; Heerspink HL; Hirayama A; Landman GWD; Levin A; Nitsch D; Wheeler DC; Coresh J; Hallan SI; Shalev V; Grams ME
Article: PLOS ONE. 2018;13(4):e0195585
Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
Mukai H; Ming P; Lindholm B; Heimburger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
Article: SCIENTIFIC REPORTS. 2018;8(1):5148
Lower serum calcium is independently associated with CKD progression
Janmaat CJ; van Diepen M; Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Elinder C-G; Rotmans JI; Vervloet M; Dekker FW; Carrero JJ
Article: SCIENTIFIC REPORTS. 2018;8(1):2103
Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism
Evans M; Methven S; Gasparini A; Barany P; Birnie K; MacNeill S; May MT; Caskey FJ; Carrero J-J
Article: PLOS ONE. 2018;13(1):e0190410
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
Alves FC; Sun J; Qureshi AR; Dai L; Snaedal S; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Article: NEPHROLOGY. 2018;23(1):31-36
Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?
Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: KIDNEY & BLOOD PRESSURE RESEARCH. 2018;43(2):522-535
Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
Mukai H; Ming P; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Article: NEPHRON. 2018;140(4):249-256
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study
Levin A; Nair D; Qureshi AR; Barany P; Heimburger O; Anderstam B; Stenvinkel P; Bruchfeld A; Ungerstedt JS
Article: PEDIATRIC NEPHROLOGY. 2018;33(1):147-157
The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Barany P
Article: PLOS ONE. 2017;12(12):e0186659
Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
Dai L; Mukai H; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(11):1892-1901
Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients
Evans M; Carrero J-J; Bellocco R; Barany P; Qureshi AR; Seeberger A; Jacobson SH; Hylander-Rossner B; Rotnitzky A; Sjolander A
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2017;12(9):1399-1408
eGFR and the Risk of Community-Acquired Infections
Xu H; Gasparini A; Ishigami J; Mzayen K; Su G; Barany P; Arnlov J; Lindholm B; Elinder CG; Matsushita K; Carrero JJ
Article: JOURNAL OF BONE AND MINERAL METABOLISM. 2017;35(5):536-543
Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients
Chen Z; Sun J; Haarhaus M; Barany P; Wennberg L; Ripsweden J; Brismar TB; Lindholm B; Wernerson A; Soderberg M; Stenvinkel P; Qureshi AR
Article: LANCET DIABETES & ENDOCRINOLOGY. 2017;5(9):718-728
Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
Matsushita K; Ballew SH; Coresh J; Arima H; Arnlov J; Cirillo M; Ebert N; Hiramoto JS; Kimm H; Shlipak MG; Visseren FLJ; Gansevoort RT; Kovesdy CP; Shalev V; Woodward M; Kronenberg F
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.p4598
P4598Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease
Szummer K; Trevisan M; Barany P; Xu H; Evans M; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii34
SO059CIRCULATING PROTEINS AS PREDICTORS OF CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS - A PROTEOMIC APPROACH
Feldreich T; Fall T; Carlsson A; Jesus-Carrero J; Qureshi A; Heimburger O; Barany P; Stenvinkel P; Arnlov J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii590
MP440OBSTRUCTIVE AND RESTRICTIVE LUNG FUNCTION ASSOCIATES WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Mukai H; Ming P; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi A
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii569-iii570
MP386KIDNEY FUNCTION AND THE RISK OF COMMUNITY ACQUIRED INFECTIONS
Xu H; Gasparini A; Ishigami J; Mzayen K; Su G; Barany P; Ärnlöv J; Lindholm B; Elinder CG; Matsushita K; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii586
MP429SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL STATUS AS PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Mukai H; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi A
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii56-iii57
MO035INFLAMMATION MODIFIES THE MORTALITY PREDICTIVE CAPACITY OF OXIDATIVE DNA DAMAGE IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Qureshi A; Mukai H; Machowska A; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii227-iii228
SP349IMPACT OF CINACALCET TREATMENT ON CARDIOVASCULAR OUTCOMES IN CKD PATIENTS WITH SECONDARY HYPERPARATHYROIDISM; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Evans M; Methven S; Sjolander A; May M; MacNeill S; Birnie K; Barany P; Carrero J-J; Caskey F
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii173
SP205CAUSES OF DEATH ACROSS REDUCED KIDNEY FUNCTION; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Runesson B; Qureshi A; Gasparini A; Barany P; Evans M; Elinder C-G; Wettermark B; Carrero J-J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii88
TO024COMBINATION OF GENOTYPE AND PHENOTYPE FEATURES AS PREDICTORS OF INFLAMMATION, CARDIOVASCULAR DISEASE AND PROTEIN ENERGY WASTING IN PATIENTS WITH CHRONIC KIDNEY DISEASES
Debowska M; Lukaszuk T; Nordfors L; Carrero JJ; Qureshi AR; Stenvinkel P; Heimburger O; Barany P; Bobrowski L; Schalling M; Lindholm B; Waniewski J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii13
SO020INAPPROPRIATE PRESCRIPTION OF NEPHROTOXIC DRUGS TO INDIVIDUALS WITH CHRONIC KIDNEY DISEASE: A COMMUNITY-BASED ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Gasparini A; Wettermark B; Schmidt-Mende K; Evans M; Qureshi AR; Barany P; Elinder C-G; Carrero J-J
Article: JOURNAL OF NEPHROLOGY. 2017;30(2):255-262
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis
Bergman A; Qureshi AR; Haarhaus M; Lindholm B; Barany P; Heimburger O; Stenvinkel P; Anderstam B
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2017;6(3):e004925
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction
Szummer K; Gasparini A; Eliasson S; Arnlov J; Qureshi AR; Barany P; Evans M; Friberg L; Carrero JJ
Article: AGING-US. 2017;9(2):494-507
CDKN2A/p16INK4^α expression is associated with vascular progeria in chronic kidney disease
Stenvinkel P; Luttropp K; McGuinness D; Witasp A; Qureshi AR; Wernerson A; Nordfors L; Schalling M; Ripsweden J; Wennberg L; Soderberg M; Barany P; Olauson H; Shiels PG
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2017;47(2):137-148
Does statins promote vascular calcification in chronic kidney disease?
Chen Z; Qureshi AR; Parini P; Hurt-Camejo E; Ripsweden J; Brismar TB; Barany P; Jaminon AM; Schurgers LJ; Heimburger O; Lindholm B; Stenvinkel P
Article: KIDNEY INTERNATIONAL. 2017;91(1):244-251
Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
Carrero JJ; Grams ME; Sang Y; Arnlov J; Gasparini A; Matsushita K; Qureshi AR; Evans M; Barany P; Lindholm B; Ballew SH; Levey AS; Gansevoort RT; Elinder CG; Coresh J
Article: KIDNEY & BLOOD PRESSURE RESEARCH. 2017;42(5):877-885
Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time
Van Craenenbroeck AH; Bragfors-Helin A-C; Qureshi AR; Lindholm B; Sjoberg B; Anderstam B; Heimburger O; Stenvinkel P; Barany P
Article: TRANSPLANTATION DIRECT. 2016;2(12):e116
Increased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy
Luttropp K; Nordfors L; McGuinness D; Wennberg L; Curley H; Quasim T; Genberg H; Sandberg J; Sonnerborg I; Schalling M; Qureshi AR; Barany P; Shiels PG; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(12):2086-2094
Prevalence and recognition of chronic kidney disease in Stockholm healthcare
Gasparini A; Evans M; Coresh J; Grams ME; Norin O; Qureshi AR; Runesson B; Barany P; Arnlov J; Jernberg T; Wettermark B; Elinder CG; Carrero J-J
Article: BONE. 2016;92:50-57
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients
Chen Z; Qureshi AR; Ripsweden J; Wennberg L; Heimburger O; Lindholm B; Barany P; Haarhaus M; Brismar TB; Stenvinkel P
Article: PLOS ONE. 2016;11(10):e0163826
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: PEDIATRIC NEPHROLOGY. 2016;31(9):1485-1497
Assessing longitudinal trends in cardiac function among pediatric patients with chronic kidney disease
Lindblad YT; Vavilis G; Axelsson J; Herthelius M; Barany P
Article: NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 2016;58:1-9
Peritoneal dialysis impairs nitric oxide homeostasis and may predispose infants with low systolic blood pressure to cerebral ischemia
Carlstrom M; Cananau C; Checa A; Wide K; Sartz L; Svensson A; Wheelock CE; Westphal S; Bekassy Z; Barany P; Lundberg JO; Hansson S; Weitzberg E; Krmar RT
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(8):1320-1327
Dialysis modality and nutritional status are associated with variability of inflammatory markers
Snaedal S; Qureshi AR; Lund SH; Germanis G; Hylander B; Heimburger O; Carrero JJ; Stenvinkel P; Barany P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2016;11(7):1163-1172
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Sun J; Axelsson J; Machowska A; Heimburger O; Barany P; Lindholm B; Lindstrom K; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i208
SP356PULMONARY DYSFUNCTION IS LINKED TO MALNUTRITION AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS
Pei M; Mukai H; Barany P; Chen Z; Heimbürger O; Lindholm B; Stenvinkel P; Qureshi AR
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i467
MP383LOW BONE MINERAL DENSITY OF LEGS AND FEMORAL NECK ASSOCIATES WITH CORONARY CALCIFICATION SCORE IN FEMALE END-STAGE RENALDISEASE PATIENTS
Chen Z; Qureshi AR; Haarhaus M; Olauson H; Heimburger O; Barany P; Ripsweden J; Brismar T; Bergström I; Lindholm B; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i334
SP713THE FGF23 AND KLOTHO AXIS IN PEDIATRIC CKD - A PROSPECTIVE COHORT STUDY
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i183-i184
SP286PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION
Van Craenenbroeck A; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Heimbürger O; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i516
MP528SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS
Mukai H; Svedberg O; Chen Z; Lindholm B; Eriksson M; Bragfors-Helin A-C; Heimbürger O; Barany P; Qureshi AR; Anderstam B; Stenvinkel P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i167
SP242GLOMERULAR FILTRATION RATE ESTIMATION USING BETA TRACE PROTEIN: EXTERNAL VALIDATION OF THREE EQUATIONS
Van Craenenbroeck AH; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Stenvinkel P; Heimbürger O
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i92-i93
SP019IS END-STAGE POLYCYSTIC KIDNEY DISEASE ASSOCIATED WITH IMPAIRMENT OF GLUCOSE METABOLISM?
Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i449
MP330LOWER CALCIUM IS ASSOCIATED WITH KIDNEY FUNCTION DECLINE IN INDIVIDUALS WITH CHRONICKIDNEY DISEASE
Janmaat CJ; van Diepen M; Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Elinder CG; Rotmans JI; Vervloet M; Dekker FW; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i191-i192
SP306PREVALENCE, DIAGNOSIS AND NEPHROLOGY CARE OF CKD IN THE REGION OF STOCKHOLM
Gasparini A; Evans M; Qureshi AR; Ärnlöv J; Barany P; Coresh J; Wettermark B; Elinder C-G; Carrero J-J
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2016;36(3):269-276
ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND WORSE CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS
Isoyama N; Machowska A; Qureshi AR; Yamamoto T; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: CLINICAL KIDNEY JOURNAL. 2016;9(1):119-127
The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
Runesson B; Gasparini A; Qureshi AR; Norin O; Evans M; Barany P; Wettermark B; Elinder CG; Carrero JJ
Article: JOURNAL OF INTERNAL MEDICINE. 2016;279(2):173-179
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
Sjoberg B; Qureshi AR; Heimburger O; Stenvinkel P; Lind L; Larsson A; Barany P; Arnlov J
Article: PLOS ONE. 2016;11(1):e0141738
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
Missailidis C; Hallqvist J; Qureshi AR; Barany P; Heimburger O; Lindholm B; Stenvinkel P; Bergman P
Article: KIDNEY INTERNATIONAL. 2015;88(6):1356-1364
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Qureshi AR; Olauson H; Witasp A; Haarhaus M; Brandenburg V; Wernerson A; Lindholm B; Soderberg M; Wennberg L; Nordfors L; Ripsweden J; Barany P; Stenvinkel P
Article: JOURNAL OF NEPHROLOGY. 2015;28(4):503-510
Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients
Cobo G; Gallar P; Gama-Axelsson T; Di Gioia C; Qureshi AR; Camacho R; Vigil A; Heimburger O; Ortega O; Rodriguez I; Carlos Herrero J; Barany P; Lindholm B; Stenvinkel P; Carrero JJ
Article: PLOS ONE. 2015;10(7):e0132353
Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
Meuwese CL; Olauson H; Qureshi AR; Ripsweden J; Barany P; Vermeer C; Drummen N; Stenvinkel P
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2015;35(4):460-470
INCREASED LEVELS OF MODIFIED ADVANCED OXIDATION PROTEIN PRODUCTS ARE ASSOCIATED WITH CENTRAL AND PERIPHERAL BLOOD PRESSURE IN PERITONEAL DIALYSIS PATIENTS
Xu H; Cabezas-Rodriguez I; Qureshi AR; Heimburger O; Barany P; Snaedal S; Anderstam B; Helin A-CB; Carrero JJ; Stenvinkel P; Lindholm B
Journal article: LAKARTIDNINGEN. 2015;112:DI7D
[The council for new therapies should immediately revoke their decision on eculizumab].
Karpman D; Fehrman-Ekholm I; Bárány P; Békássy Z; Brandström P; Bruchfeld A; Celsi G; Chromek M; Clyne N; Fellström B; Hansson S; Haraldsson B; Nevéus T; Rippe B; Sartz L; Segelmark M; Stegmayr B; Stenvinkel P; Westman K
Journal article: LAKARTIDNINGEN. 2015;112:DI3F
[The council for new therapies position on eculizumab is unacceptable].
Karpman D; Fehrman-Ekholm I; Bárány P; Békássy Z; Brandström P; Bruchfeld A; Celsi G; Chromek M; Clyne N; Fellström B; Hansson S; Haraldsson B; Nevéus T; Rippe B; Sartz L; Segelmark M; Stegmayr B; Stenvinkel P; Tufveson G; Westman K
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(suppl_3):iii565
SP564HIGH SENSITIVE TROPONIN T AND TROPONIN I THREE MONTH VARIATION IN PREVALENT HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Snaedal S; Bárány P; Qureshi AR; Heimbürger O; Stenvinkel P; Löwbeer C; Szummer K
Article: CLINICAL KIDNEY JOURNAL. 2015;8(2):215-218
Plasma nitrate/nitrite removal by peritoneal dialysis might predispose infants with low blood pressure to cerebral ischaemia
Carlstrom M; Wide K; Lundvall M; Cananau C; Svensson A; Lundberg JO; Barany P; Krmar RT
Article: CARDIORENAL MEDICINE. 2015;5(2):89-95
High Levels of Soluble Tumor Necrosis Factor Receptors 1 and 2 and Their Association with Mortality in Patients Undergoing Hemodialysis
Carlsson AC; Carrero J-J; Stenvinkel P; Bottai M; Barany P; Larsson A; Arnlov J
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2015;35(2):206-215
OXIDATIVE DNA DAMAGE AND MORTALITY IN HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Xu H; Watanabe M; Qureshi AR; Heimburger O; Barany P; Anderstam B; Eriksson M; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(2):274-282
Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting
Yuan J; Watanabe M; Suliman M; Qureshi AR; Axelsson J; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2015;75(8):652-658
Validation of a competitive ELISA assay for the quantification of human serum hepcidin
Dahlfors G; Stal P; Hansson EC; Barany P; Sisowath C; Onelov L; Nelson D; Eggertsen G; Marmur J; Beshara S
Article: BLOOD PURIFICATION. 2015;39(4):259-265
Endostatin, Cathepsin S, and Cathepsin L, and Their Association with Inflammatory Markers and Mortality in Patients Undergoing Hemodialysis
Carlsson AC; Carrero J-J; Stenvinkel P; Bottai M; Barany P; Larsson A; Arnlov J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(1):84-91
Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients
Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: LAKARTIDNINGEN. 2014;111:C7XL
Apropå! Rätt ska vara rätt om Njurknappen och NjuRen - NjuRen på väg in i flera landsting.
Bárány P; Shemeikk T
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;9(10):1720-1728
Comparative Associations of Muscle Mass and Muscle Strength with Mortality in Dialysis Patients
Isoyama N; Qureshi AR; Avesani CM; Lindholm B; Barany P; Heimburger O; Cederholm T; Stenvinkel P; Carrero JJ
Article: CLINICAL KIDNEY JOURNAL. 2014;7(4):373-379
Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
Sjoberg B; Snaedal S; Stenvinkel P; Qureshi AR; Heimburger O; Barany P
Article: CLINICAL KIDNEY JOURNAL. 2014;7(3):275-281
Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
Danielson K; Beshara S; Qureshi AR; Heimburger O; Lindholm B; Hansson M; Hylander B; Germanis G; Stenvinkel P; Barany P
Article: ANGIOLOGY. 2014;65(5):443-449
Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4
Ghanavatian S; Diep LM; Barany P; Heimburger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
Article: CLINICAL KIDNEY JOURNAL. 2014;7(2):151-155
Systematic conversion to generic tacrolimus in stable kidney transplant recipients
Rosenborg S; Nordstrom A; Almquist T; Wennberg L; Barany P
Article: PLOS ONE. 2014;9(1):e86630
Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method
Bobrowski L; Lukaszuk T; Lindholm B; Stenvinkel P; Heimburger O; Axelsson J; Barany P; Carrero JJ; Qureshi AR; Luttropp K; Debowska M; Nordfors L; Schalling M; Waniewski J
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;9(1):120-127
IGF-1 and Survival in ESRD
Jia T; Gama Axelsson T; Heimburger O; Barany P; Lindholm B; Stenvinkel P; Qureshi AR
Article: BLOOD PURIFICATION. 2014;37(2):138-145
Determinants of N-Terminal Pro-Brain Natriuretic Peptide Variation in Hemodialysis Patients and Prediction of Survival
Snaedal S; Qureshi AR; Carrero JJ; Heimburger O; Stenvinkel P; Barany P
Journal article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 2013;23:s52-s53
Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease
Lindblad YT; Axelsson J; Bárány P; Celsi G; Lindholm B; Qureshi AR; Carrea A; Canepa A
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(6):584-593
Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?
Meuwese CL; Carrero JJ; Cabezas-Rodriguez I; Heimburger O; Barany P; Lindholm B; Qureshi AR; Ripsweden J; Dekker FW; Stenvinkel P
Journal article: LAKARTIDNINGEN. 2013;110(47):2122
[It is better use a modern formula than being formal].
Elinder C-G; Bárány P; Heimbürger O
Article: LAKARTIDNINGEN. 2013;110(47):2119-2120
[Drug dosage should be based on renal function].
Elinder C-G; Bárány P; Heimbürger O
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:iv175-iv181
Subclinical versus overt obesity in dialysis patients: more than meets the eye
Gracia-Iguacel C; Qureshi AR; Avesani CM; Heimburger O; Huang X; Lindholm B; Barany P; Ortiz A; Stenvinkel P; Carrero JJ
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2013;174(3):441-448
Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality
Frostegard AG; Hua X; Su J; Carrero JJ; Heimburger O; Barany P; Stenvinkel P; Frostegard J
Article: PEDIATRIC NEPHROLOGY. 2013;28(10):2003-2013
Left ventricular diastolic dysfunction by tissue Doppler echocardiography in pediatric chronic kidney disease
Lindblad YT; Axelsson J; Balzano R; Vavilis G; Chromek M; Celsi G; Barany P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28(9):2356-2363
Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients
Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28(6):1346-1359
Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Locatelli F; Barany P; Covic A; De Francisco A; Del Vecchio L; Goldsmith D; Hoerl W; London G; Vanholder R; Van Biesen W
Article: JOURNAL OF NEPHROLOGY. 2013;26(3):485-494
Determinants and survival implications of low bone mineral density in end-stage renal disease patients
Park S-H; Jia T; Qureshi AR; Barany P; Heimburger O; Larsson TE; Axelsson J; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28(suppl_1):i35-i36
Peritoneal dialysis - clinical
Bertoli S; Stucchi A; Ciurlino D; Musetti C; Meuwese CL; Carrero JJ; Cabezas-Rodriguez I; Heimburger O; Barany P; Lindholm B; Qureshi AR; Ripsweden J; Dekker FW; Stenvinkel P; Eser B; Buyukbakkal M; Yayar O; Yildirim T; Ercan Z; Kali A; Erdogan B; Haspulat A; Merhametsiz O; Akdag S; Ayli M; Keles H; Kendi Celebi Z; Karatan O; Ates K; Lambie M; Chess J; Bankart MJ; Lee HB; Noh H; Do JY; Dorval M; Topley N; Davies SJ; van Diepen ATN; van Esch S; Krediet RT; Struijk DG
Article: JOURNAL OF RENAL NUTRITION. 2013;23(2):106-113
Self-Rated Appetite as a Predictor of Mortality in Patients With Stage 5 Chronic Kidney Disease
Gama-Axelsson T; Lindholm B; Barany P; Heimbuerger O; Stenvinkel P; Qureshi AR
Article: JOURNAL OF INTERNAL MEDICINE. 2013;273(3):263-272
Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients
Huang X; Stenvinkel P; Qureshi AR; Cederholm T; Barany P; Heimburger O; Lindholm B; Riserus U; Carrero JJ
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2013;37(5):462-471
Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients
Jia T; Qureshi AR; Brandenburg V; Ketteler M; Barany P; Heimburger O; Uhlin F; Magnusson P; Fernstrom A; Lindholm B; Stenvinkel P; Larsson TE
Journal article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(11):1915
Serum albumin as predictor of nutritional status in patients with ESRD (vol 7, pg 1446, 2012)
Gama-Axelsson T; Heimbuerger O; Stenvinkel P; Barany P; Lindholm B; Qureshi AR
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(11):3973-3974
The enigma of decreased creatinine generation in acute kidney injury
Heimbuerger O; Stenvinkel P; Barany P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(9):3615-3620
Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients
Huang X; Stenvinkel P; Qureshi AR; Riserus U; Cederholm T; Barany P; Heimburger O; Lindholm B; Carrero JJ
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(9):1446-1453
Serum Albumin as Predictor of Nutritional Status in Patients with ESRD
Gama-Axelsson T; Heimburger O; Stenvinkel P; Barany P; Lindholm B; Qureshi AR
Article: JOURNAL OF RENAL NUTRITION. 2012;22(2):277-283
Plasma Fatty Acids in Chronic Kidney Disease: Nervonic Acid Predicts Mortality
Shearer GC; Carrero JJ; Heimbuerger O; Barany P; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(2):709-715
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease
Carrero JJ; Barany P; Yilmaz MI; Qureshi AR; Sonmez A; Heimburger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(1):70-75
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease
Breit SN; Carrero JJ; Tsai VW-W; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami M-A; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
Article: BLOOD PURIFICATION. 2012;34(3-4):290-297
Pentraxin 3, a Sensitive Early Marker of Hemodialysis-Induced Inflammation
Sjoberg B; Qureshi AR; Anderstam B; Alvestrand A; Barany P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(1):131-138
Baseline Levels and Trimestral Variation of Triiodothyronine and Thyroxine and Their Association with Mortality in Maintenance Hemodialysis Patients
Meuwese CL; Dekker FW; Lindholm B; Qureshi AR; Heimburger O; Barany P; Stenvinkel P; Carrero JJ
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011;6(12):2785-2791
Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease
Miyamoto T; Qureshi AR; Heimburger O; Barany P; Carrero K; Sjoberg B; Lindholm B; Stenvinkel P; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(10):3237-3242
New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
Smerud HK; Barany P; Lindstrom K; Fernstrom A; Sandell A; Pahlsson P; Fellstrom B
Article: JOURNAL OF NEPHROLOGY. 2011;24(5):589-596
Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease
Wikstrom B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
Journal article: CLINICAL KIDNEY JOURNAL. 2011;4(suppl_2):4.s2.9
Treatment of malnutrition and anaemia
Xu Z; Chen Y; Huang A; Varghese Z; Moorhead J; Powis S; Li Q; Ruan X; Espe KM; Raila J; Henze A; Krane V; Schweigert FJ; Hocher B; Wanner C; Drechsler C; Sahni N; Gupta KL; Prasad R; Rana SV; Bhalla A; Carrero JJ; Barany P; Yilmaz MI; Qureshi AR; Sonmez A; Heimburger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P; Schneider A; Drechsler C; Krane V; Krieter DH; Fraass U; Schneider MP; Wanner C; Leu K; Mortensen R; Worth A; Singh S; Schatz P; Young P; Wojchowski D; Green J
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011;6(5):1001-1008
Circulating Follistatin in Patients with Chronic Kidney Disease: Implications for Muscle Strength, Bone Mineral Density, Inflammation, and Survival
Miyamoto T; Carrero JJ; Qureshi AR; Anderstarn B; Heimburger O; Barany P; Lindholm B; Stenvinkel P
Article: KIDNEY INTERNATIONAL. 2011;79(7):749-756
Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients
Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimburger O; Barany P; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(4):1313-1318
Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients
Meuwese CL; Snaedal S; Halbesma N; Stenvinkel P; Dekker FW; Qureshi AR; Barany P; Heimburger O; Lindholm B; Krediet RT; Boeschoten EW; Carrero JJ
Article: CLINICAL NEPHROLOGY. 2011;75:S4-S10
Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange
Krmar RT; Holtback U; Linne T; Berg UB; Celsi G; Soderberg MP; Wernerson A; Szakos A; Larsson S; Skatturn L; Barany P
Journal article: CLINICAL NUTRITION. 2011;6(1):156
PP112-MON SELF-RATED APPETITE IS A POOR PREDICTOR OF MORTALITY IN PRE-DIALYSIS AND DIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Axelsson TG; Lindholm B; Heimburger O; Stenvinkel P; Barany P; Qureshi AR
Journal article: CLINICAL NUTRITION. 2011;6(1):156
PP111-MON SERUM ALBUMIN (S-ALB) AS PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN END-STAGE RENAL DISEASE (ESRD) PATIENTS (PTS)
Axelsson TG; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(1):184-190
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease
Carrero JJ; Qureshi AR; Nakashima A; Arver S; Parini P; Lindholm B; Barany P; Heimbuerger O; Stenvinkel P
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2011;33(1):17-24
Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis
Cordeiro AC; Carrero JJ; Barany P; Qureshi AR; Heimburger O; Lindholm B; Stenvinkel P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2010;5(12):2213-2219
Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients
Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(12):4017-4023
Clinical importance of an elevated circulating chemerin level in incident dialysis patients
Yamamoto T; Qureshi AR; Anderstam B; Heimburger O; Barany P; Lindholm B; Stenvinkel P; Axelsson J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(11):3717-3723
Variations in C-reactive protein during a single haemodialysis session do not associate with mortality
Meuwese CL; Halbesma N; Stenvinkel P; Dekker FW; Molanaei H; Qureshi AR; Barany P; Heimburger O; Lindholm B; Krediet RT; Boeschoten EW; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(9):3033-3038
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
Olauson H; Qureshi AR; Miyamoto T; Barany P; Heimburger O; Lindholm B; Stenvinkel P; Larsson TE
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(3):901-906
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
Carrero JJ; Witasp A; Stenvinkel P; Qureshi AR; Heimburger O; Barany P; Suliman ME; Anderstam B; Lindholm B; Nordfors L; Schalling M; Axelsson J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(2):562-568
Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis
Cordeiro AC; Qureshi AR; Stenvinkel P; Heimburger O; Axelsson J; Barany P; Lindholm B; Carrero JJ
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2009;54(6):1072-1080
Soluble CD14 Levels, Interleukin 6, and Mortality Among Prevalent Hemodialysis Patients
Raj DSC; Carrero JJ; Shah VO; Qureshi AR; Barany P; Heimburger O; Lindholm B; Ferguson J; Moseley PL; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009;24(11):3468-3473
Associations of VEGF and its receptors sVEGFR-1 and-2 with cardiovascular disease and survival in prevalent haemodialysis patients
Guo Q; Carrero JJ; Yu X; Barany P; Qureshi AR; Eriksson M; Anderstam B; Chmielewski M; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009;24(11):3454-3460
Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis
Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimburger O; Barany P; Lindholm B; Frostegard J
Article: TRANSPLANT INTERNATIONAL. 2009;22(11):1051-1057
Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking
Elinder C-G; Ekberg H; Barany P; Fehrman-Ekholm I; Jensen G; Norden G; Schon S; Wennberg L; Qureshi AR
Article: JOURNAL OF NEPHROLOGY. 2009;22(6):774-782
Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimburger O; Barany P; Alvestrand A; Lindholm B; Suliman ME
Article: JOURNAL OF INTERNAL MEDICINE. 2009;265(6):708-716
Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients
Chmielewski M; Carrero JJ; Qureshi AR; Axelsson J; Heimburger O; Berglund L; Barany P; Rutkowski B; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2009;53(6):1024-1033
Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient Survival
Snaedal S; Heimburger O; Qureshi AR; Danielsson A; Wikstrom B; Fellstrom B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Barany P
Article: CLINICAL NEPHROLOGY. 2009;71(4):397-404
Intercurrent events and comorbid conditions influence hemoglobin level variability in dialysis patients
DeFrancisco ALM; Macdougall IC; Carrera F; Braun J; Barany P; Bridges I; Wheeler T; Tran D; Dietrich A
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009;20(3):613-620
Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero JJ; Qureshi AR; Parini P; Arver S; Lindholm B; Barany P; Heimburger O; Stenvinkel P
Article: MOLECULAR MEDICINE. 2009;15(3-4):70-75
Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation
Bruchfeld A; Carrero JJ; Qureshi AR; Lindholm B; Barany P; Heimburger O; Hu M; Lin X; Stenvinkel P; Miller EJ
Article: LAKARTIDNINGEN. 2009;106(7):420-421
[Choose the right method fo estimation of kidney function. The nature of the problem determines which method should be used].
Heimbürger O; Bárány P
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2009;29(6):516-523
N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients
Guo Q; Barany P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2009;29(5):447-453
Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5
Axelsson J; O'Byrne SM; Blaner WS; Carrero JJ; Bruchfeld A; Heimbuerger O; Barany P; Lindholm B; Stenvinkel P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009;4(1):110-118
Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients
Carrero JJ; Ortiz A; Qureshi AR; Martin-Ventura JL; Barany P; Heimburger O; Marron B; Metry G; Snaedal S; Lindholm B; Egido J; Stenvinkel P; Blanco-Colio LM
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2008;38(11):804-811
Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients
Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Barany P; Snaedal S; Heimbuerger O; Lindholm B; Suliman ME
Article: CLINICA CHIMICA ACTA. 2008;395(1-2):106-110
Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients
Valli A; Carrero JJ; Qureshi AR; Garibotto G; Barany P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
Article: CLINICAL NUTRITION. 2008;27(4):557-564
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimburger O; Barany P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2008;3(4):976-985
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease
Suliman ME; Yimaz MI; Carrero JJ; Qureshi AR; Saglam M; Ipcioglu OM; Yenicesu M; Tong M; Heimbuerger O; Barany P; Alvestrand A; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2008;87(6):1860-1866
Consequences of low plasma histidine in chronic kidney disease patients:: associations with inflammation, oxidative stress, and mortality
Watanabe M; Suliman ME; Qureshi AR; Garcia-Lopez E; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Article: QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. 2008;101(5):397-405
The long pentraxin PTX-3 in prevalent hemodialysis patients:: associations with comorbidities and mortality
Suliman ME; Qureshi AR; Carrero JJ; Barany P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimburger O; Lindholm B; Stenvinkel P
Article: JOURNAL OF INTERNAL MEDICINE. 2008;263(3):302-312
Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients
Carrero JJ; Stenvinkel P; Fellstrom B; Qureshi AR; Lamb K; Heimburger O; Barany P; Radhakrishnan K; Lindholm B; Soveri I; Nordfors L; Shiels PG
Article: MOLECULAR MEDICINE. 2008;14(3-4):109-115
High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
Bruchfeld A; Qureshi AR; Lindholm B; Barany P; Yang L; Stenvinkel P; Tracey KJ
Journal article: CLINICAL NUTRITION. 2008;3:156-157
P300 MUSCLE ATROPHY, INFLAMMATION AND CLINICAL OUTCOME IN INCIDENT AND PREVALENT DIALYSIS PATIENTS
Carrero JJ; Chmielewski M; Heimburger O; Barany P; Lindholm B; Qureshi AR; Stenvinkel P
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2008;28(4):669-676
Is fetuin-A/α2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
Axelsson J; Wang X; Ketteler M; Qureshi AR; Heimburger O; Barany P; Lindholm B; Nordfors L; Stenvinkel P
Article: BLOOD PURIFICATION. 2008;26(3):284-290
Bone mineral density in end-stage renal disease patients:: Association with wasting, cardiovascular disease and mortality
Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbuerger O; Barany P; Stenvinkel P; Lindholm B
Article: BLOOD PURIFICATION. 2008;26(6):555-560
Lipoprotein Lipase 1595 C/G and Hepatic Lipase-480 C/T Polymorphisms - Impact on Lipid Profile in Incident Dialysis Patients
Chmielewski M; Stenvinkel P; Luttropp K; Suliman ME; Qureshi AR; Carrero JJ; Barany P; Heimburger O; Nordfors L; Lindholm B
Article: BLOOD PURIFICATION. 2008;26(6):518-525
Hyperinsulinemia and Insulin Resistance, Early Cardiovascular Risk Factors in Children with Chronic Kidney Disease
Lindblad YT; Axelsson J; Barany P; Celsi G; Lindholm B; Qureshi AR; Carrea A; Canepa A
Article: JOURNAL OF INTERNAL MEDICINE. 2007;262(6):690-701
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease
Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Barany P; Heimburger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(12):3586-3592
Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients
Girndt M; Stenvinkel P; Ulrich C; Axelsson J; Nordfors L; Barany P; Carrero JJ; Heine GH; Kaul H; Koehler H
Article: SEMINARS IN DIALYSIS. 2007;20(6):523-529
Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients
Suliman ME; Lindholm B; Barany P; Qureshi AR; Stenvinkel P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;86(3):633-638
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality
Honda H; Qureshi AR; Axelsson J; Heimburger O; Suliman ME; Barany P; Stenvinkel P; Lindholm B
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2007;2(5):889-897
Plasma pentraxin 3 in patients with chronic kidney disease:: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality
Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimburger O; Barany P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(9):2571-2577
Association between oestrogen receptor α gene polymorphism and mortality in female end-stage renal disease patients
Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimburger O; Gustafsson J-A; Stenvinkel P; Nordfors L
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:iv10-iv18
Maintaining control over haemoglobin levels:: optimizing the management of anaemia in chronic kidney disease
Barany P; Mueller H-J
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(5):488-499
Impact of inflammation on epigenetic DNA methylation -: a novel risk factor for cardiovascular disease?
Stenvinkel P; Karimi M; Johansson S; Axelsson J; Suliman M; Lindholm B; Heimburger O; Barany P; Alvestrand A; Nordfors L; Qureshi AR; Ekstrom TJ; Schalling M
Article: CLINICA CHIMICA ACTA. 2007;379(1-2):87-94
Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors
Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;85(3):695-701
Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetites
Carrero JJ; Qureshi AR; Axelsson J; Avesani CM; Suliman ME; Kato S; Barany P; Snaedal-Jonsdottir S; Alvestrand A; Heimburger O; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2007;49(2):237-244
Circulating levels of Visfatin/Pre-B-Cell colony-enhancing factor 1 in relation to genotype,GFR, body composition, and survival in patients with CKD
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbuerger O; Barany P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(1):209-217
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Barany P; Heimburger O; Vonesh EF; Lindholm B
Article: BLOOD PURIFICATION. 2007;25(2):210-218
Associations between the CYBA 242C/T and the MPO-463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients
Grahl DA; Axelsson J; Nordfors L; Heimburger O; Barany P; Qureshi AR; Kato S; Watanabe M; Suliman M; Riella MC; Lindholm B; Stenvinkel P; Pecoits-Filho R
Article: ORAL HEALTH & PREVENTIVE DENTISTRY. 2007;5(3):235-244
Oral health and pro-inflammatory status in end-stage renal disease patients.
Buhlin K; Bárány P; Heimbürger O; Stenvinkel P; Gustafsson A
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(1):196-202
Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism
Wang X; Axelsson J; Nordfors L; Qureshi AR; Avesani C; Barany P; Schalling M; Heimburger O; Lindholm B; Stenvinkel P
Article: CLINICAL NEPHROLOGY. 2006;66(6):418-425
Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy
Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Barany P; Heimburger O; Lindholm B
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;48(6):916-925
Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD
Axelsson J; Moller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimburger O; Barany P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;48(5):761-771
J-shaped mortality relationship for uric acid in CKD
Suliman ME; Johnson RJ; Garcia-Lopez E; Qureshi AR; Molinaei H; Carrero JJ; Heimburger O; Barany P; Axelsson J; Lindholm B; Stenvinkel P
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2006;60(6):718-726
Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
Axelsson J; Qureshi AR; Divino-Filho JC; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2006;1(2):281-287
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients
Stenvinkel P; Rodriguez-Ayala E; Massy ZA; Qureshi AR; Barany P; Fellstrom B; Heimburger O; Lindholm B; Alvestrand A
Article: KIDNEY INTERNATIONAL. 2006;69(3):596-604
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance
Axelsson J; Bergsten A; Qureshi AR; Heimbürger O; Bárány P; Lönnqvist FL; Lindholm B; Nordfors L; Alvestrand A; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;47(1):139-148
Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21(1):125-132
Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging
Hayashi SY; Rohani M; Lindholm B; Brodin L; Lind B; Barany P; Alvestrand A; Seeberger A
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2005;46(4):628-634
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD
Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
Article: LAKARTIDNINGEN. 2005;102(37):2536-2537
[Iron deficiency in renal anemia is difficult to diagnose. Evidence-based guidelines improve diagnosis and treatment].
Bárány P
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:2-7
Inflammation and resistance to erythropoiesis-stimulating agents - what do we know and what needs to be clarified?
Smrzova J; Balla J; Bárány P
Article: ATHEROSCLEROSIS. 2005;182(1):105-111
Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20 Suppl 8:viii2-viii7
Inflammation and resistance to erythropoiesis-stimulating agents--what do we know and what needs to be clarified?
Smrzova J; Balla J; Bárány P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2005;82(2):342-349
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease
Suliman ME; Qureshi AR; Stenvinkel P; Pecoits R; Bárány P; Heimbürger O; Anderstam B; Ayala ER; Divino JC; Alvestrand A; Lindholm B
Article: KIDNEY INTERNATIONAL. 2005;67(6):2383-2392
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin
Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L
Article: LAKARTIDNINGEN. 2005;102(5):281-282
[Selection of dialysis type--a crucial decision. Peritoneal dialysis is better for the patient and cheaper for the society].
Jonsdottir SS; Stenvinkel P; Bárány P
Article: BLOOD PURIFICATION. 2005;23(5):384-393
Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease
Maruyama Y; Nordfors L; Stenvinkel P; Heimbürger O; Bárány P; Pecoits R; Axelsson J; Hoff CM; Holmes CJ; Schalling M; Lindholm B
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2004;44(3):455-465
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimbürger O; Anderstam B; Alvestrand A; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19(7):1823-1828
Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease
Nascimento MM; Qureshi AR; Stenvinkel P; Pecoits-Filho R; Heimbürger O; Cederholm T; Lindholm B; Bárány P
Article: JOURNAL OF NEPHROLOGY. 2004;17(4):525-530
Varying intervals of subcutaneous epoetin alfa in hemodialysis patients
Beshara S; Bárány P; Gutierrez A; Wikström B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19 Suppl 2:ii1
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.
Locatelli F; Aljama P; Bárány P; Canaud B; Carrera F; Eckardt K-U; Hörl WH; Macdougal IC; Macleod A; Wiecek A; Cameron S; European Best Practice Guidelines Working Group
Article: KIDNEY INTERNATIONAL. 2004;65(1):274-281
Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin
Stenvinkel P; Marchlewska A; Pecoits R; Heimbürger O; Zhang ZZ; Hoff C; Holmes C; Axelsson J; Arvidsson S; Schalling M; Barany P; Lindholm B; Nordfors L
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2003;41(6):1212-1218
Associations between circulating inflammatory markers and residual renal function in CRF patients
Pecoits R; Heimbürger O; Bárány P; Suliman M; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14(6):1614-1622
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy
Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits R; Ayala ER; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2002;40(6):E22-e22.4
Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor
Donne RL; Abbs I; Barany P; Elinder CG; Little M; Conlon P; Goodship THJ
Article: KIDNEY INTERNATIONAL. 2002;62(6):2167-2175
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients
Vanrenterghem Y; Bárány P; Mann JFE; Kerr PG; Wilson J; Baker NF; Gray SJ
Article: LAKARTIDNINGEN. 2002;99(42):4162-4163
[Unusual but serious adverse effect. Epoetin treatment of patients with kidney diseases caused erythroblastopenia].
Stenvinkel P; Bárány P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2002;40(3):480-488
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(9):1684-1688
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment
Pecoits-Filho R; Bárány P; Lindholm B; Heimbürger O; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(7):1266-1274
A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients
Stenvinkel P; Barany P; Chung SH; Lindholm B; Heimbürger O
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(6):1050-1056
Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease
Suliman ME; Bárány P; Divino JC; Qureshi AR; Stenvinkel P; Heimbürger O; Anderstam B; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2001;16(3):580-584
Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers
Bárány P; Stenvinkel B; Ottosson-Seeberger A; Alvestrand A; Morrow J; Roberts JJ; Salahudeen AK
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2001;16(2):224-227
Inflammation, serum C-reactive protein, and erythropoietin resistance
Bárány P
Article: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2001;39(8):734-738
Hyperhomocysteinemia in chronic renal failure patients: Relation to nutritional status and cardiovascular disease
Suliman ME; Lindholm B; Bárány P; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2001;16(1):102-110
Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients
Suliman ME; Divino JC; Bárány P; Anderstam B; Lindholm B; Bergström J
Article: JOURNAL OF RENAL CARE. 1999;25(4):42-44
An educational programme for persistent life-style changes in patients with chronic renal disease.
Bergström K; Bárány P; Holm I
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1999;10(6):1287-1296
Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients
Suliman ME; Divino JC; Bàràny P; Anderstam B; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 1997;12(11):2339-2348
Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients
Divino JC; Barany P; Stehle P; Furst P; Bergstrom J
Article: CLINICAL NEPHROLOGY. 1997;48(1):1-8
Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients
Drueke TB; Barany P; Cazzola M; Eschbach JW; Grutzmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; vanWyck D
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 1997;29(4):565-568
High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
Barany P; Divino JC; Bergstrom J
Article: PERITONEAL DIALYSIS INTERNATIONAL. 1995;15(1):54-60
SUBCUTANEOUS EPOETIN-BETA IN RENAL ANEMIA - AN OPEN MULTICENTER DOSE TITRATION STUDY OF PATIENTS ON CONTINUOUS PERITONEAL-DIALYSIS
BARANY P; CLYNE N; HYLANDER B; JOHANSSON AC; SIMONSEN O; LARSSON R; FRISENETTEFICH C; SVENSSON B; HELMERS C
Journal article: BIODRUGS. 1994;1(6):469-480
IMMUNOLOGICAL ASPECTS OF HEMODIALYSIS
BARANY P; FEHRMANEKHOLM I
Journal article: DIALYSIS AND TRANSPLANTATION. 1994;23(1):30-36
PERITONEAL TRANSPORT AND EPO
HEIMBURGER O; BARANY P; TRANAEUS A; WANIEWSKI J; WERYNSKI A; PARK MS; LINDHOLM B
Journal article: CLINICAL NEPHROLOGY. 1993;40(3):168-175
DAILY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) IN PERITONEAL-DIALYSIS PATIENTS - A EUROPEAN DOSE-RESPONSE STUDY
FALLER B; SLINGENEYER A; WALLER M; MICHEL C; GRUTZMACHER P; MULLER HP; BARANY P; GRABENSEE B; ISSAD B; SCHMITT H; MEISL F
Journal article: CLINICAL SCIENCE. 1993;84(4):441-447
TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS WITH ERYTHROPOIETIN - LONG-TERM EFFECTS ON EXERCISE CAPACITY
BARANY P; FREYSCHUSS U; PETTERSSON E; BERGSTROM J
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 1993;8(5):426-432
LONG-TERM EFFECTS ON QUALITY-OF-LIFE IN HEMODIALYSIS-PATIENTS OF CORRECTION OF ANEMIA WITH ERYTHROPOIETIN
BARANY P; PETTERSSON E; KONARSKISVENSSON JK
Journal article: CLINICAL NEPHROLOGY. 1992;38(1):53-57
CLOSTRIDIUM-DIFFICILE INFECTION - A POOR PROGNOSTIC SIGN IN UREMIC PATIENTS
BARANY P; STENVINKEL P; NORD CE; BERGSTROM J
Journal article: CLINICAL NEPHROLOGY. 1992;37(2):90-96
LONG-TERM EFFECTS ON LYMPHOCYTOTOXIC ANTIBODIES AND IMMUNE REACTIVITY IN HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
BARANY P; FEHRMAN I; GODOY C
Journal article: CLINICAL SCIENCE. 1991;81(5):645-653
ATP PRODUCTION IN ISOLATED MUSCLE MITOCHONDRIA FROM HEMODIALYSIS-PATIENTS - EFFECTS OF CORRECTION OF ANEMIA WITH ERYTHROPOIETIN
BARANY P; WIBOM R; HULTMAN E; BERGSTROM J
Journal article: LAKARTIDNINGEN. 1991;88(36):2855-2857
[Erythropoietin is highly effective in renal anemia but should be prescribed with caution].
Bárány P
Journal article: CLINICAL NEPHROLOGY. 1991;35(6):270-279
NUTRITIONAL ASSESSMENT IN ANEMIC HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
BARANY P; PETTERSON E; AHLBERG M; HULTMAN E; BERGSTROM J
Journal article: CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY. 1991;88:169-179
Long-term effects of recombinant human erythropoietin in patients treated with continuous peritoneal dialysis: safety aspects.
Bárány P; Tranaeus A; Bergström J
Journal article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 1990;50(3):337-341
DECREASED CONCENTRATIONS OF DEOXYCHOLIC-ACID IN SERUM OF UREMIC PATIENTS WITH DIARRHEA
STENVINKEL P; BARANY P; BJORKHEM I; EINARSSON K
Journal article: TRANSPLANTATION PROCEEDINGS. 1990;22(1):147-148
MEASURES TO DECREASE HLA ANTIBODIES IN IMMUNIZED PATIENTS AWAITING KIDNEY-TRANSPLANTATION
FEHRMAN I; BARANY P; BJORCK S; BERGSTROM J; STELIN G; KONAR J; SANDBERG L; SODERSTROM T; LUNDGREN G; BRYNGER H
Journal article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 1990;131:55-60
ERYTHROPOIETIN TREATMENT IMPROVES QUALITY-OF-LIFE IN HEMODIALYSIS-PATIENTS
BARANY P; PETTERSSON E; BERGSTROM J
Journal article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY. 1987;6(3):352-356
CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA IN UREMIC PATIENTS
ARONSSON B; BARANY P; NORD CE; NYSTROM B; STENVINKEL P
Show more

All other publications

Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2025;54:197-198
Temporal trends and determinants of infection in Lupus nephritis patients with chronic kidney disease
Chrysostomou C; Faustini F; Gunnarsson I; Barany P; Evans M; Faucon A-L
Conference publication: PEDIATRIC NEPHROLOGY. 2024;39(1):S253
Focal segmental glomerulosclerosis in the girl with MIRAGE Syndrome
Niwinska-Faryna B; Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2024;39(1):S249
COVID-19-induced tubulointerstitial nephritis in an infant with multisystem inflammatory syndrome
Niwinska-Faryna B; Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2024;39(1):S63
Extracellular DNA in children with chronic kidney disease
Lindblad YT; Tothova L; Celec P; Kublickiene K; Barany P; Chromek M
Conference publication: 2024;:a41-a42
O44 Long-term outcomes of chronic kidney disease patients with lupus nephritis: a nationwide cohort study
Chrysostomou C; Faucon A-L; Faustini F; Gunnarsson I; Barany P; Evans M
Editorial: CLINICAL KIDNEY JOURNAL. 2023;16(10):1541-1542
Lifelong statins for long life in dialysis patients?
Ebert T; Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2023;38:S175-S176
CLINICAL COURSE AND OUTCOME OF THREE ANCA AND ANTI-GBM POSITIVE TEENAGE PATIENTS
Niwinska-Faryna B; Barany P; Chrome M
Conference publication: PEDIATRIC NEPHROLOGY. 2022;37(11):2851-2852
RENAL FUNCTION IN SURVIVORS OF HYPOTHERMIA-TREATED HYPOXIC-ISCHAEMIC ENCEPHALOPATHY AFTER 10-12 YEARS
Grossmann KR; Vishnevskaya L; Blennow M; Barany P; Chromek M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11):246-247
Burden of Anemia in Patients With CKD Stages 3-5 Managed in Primary Care
Evans M; Xu Y; Mazhar F; Arnlov J; Cockburn E; Barany PF; Carrero JJ
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022;33(11):231
Blood-Brain-Barrier Biomarkers in Patients Before and After Kidney Transplantation
Hernandez LN; Ward LJ; Arefin S; Barany PF; Stenvinkel P; Kublickiene K
Conference publication: EUROPEAN HEART JOURNAL. 2022;43:1563
Prognosis after aortic valve replacement in dialysis patients: results from the Swedish Renal Registry
Vavilis G; Back M; Barany P; Ruck A; Szummer K
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:632
Use of potential nephrotoxic medications among adults with CKD: Parallel cohort studies in US and Swedish routine care
Xu Y; Bosi A; Gasparini A; Wettermark B; Barany P; Inker L; Chang A; Grams M; Carrero J; Shin J-I
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37:I901
NOVEL GLUCOSE-LOWERING DRUGS AND THE RISK OF ACUTE KIDNEY INJURY IN ROUTINE CARE: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Alkas J; Bosi A; Sjolander A; Barany FP; Elinder C-G; Fu E; Carrero JJ
Editorial: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;16(11):1613-1614
Muscle Abnormalities with Kidney Failure
Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2021;36(10):3324
ACUTE KIDNEY INJURY AFTER ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN - A SINGLE CENTRE OBSERVATIONAL STUDY
Larsson E; Sundin M; Barany P; Chromek M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(10):188
Serum Erythroferrone and Serum Hepcidin 25 Are Associated with CKD
Pistis KD; Qureshi ART; Stenvinkel P; Lindholm B; Barany PF
Preprint: RESEARCH SQUARE. 2020
Inverse association of transferrin saturation with mortality risk in chronic kidney disease
Li X; Danielson K; Forsal I; Iseri K; Dai L; Heimbürger O; Bárány P; Yu C; Qureshi AR; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
THE ASSOCIATION BETWEEN RENAL FUNCTION AND TROPONIN T OVER TIME IN STABLE CKD PATIENTS
Chesnaye N; Szummer K; Barany P; Heimburger O; Magin H; Uhlin F; Dekker FW; Wanner C; Jager K; Evans M
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34:175
DYNAMIC PREDICTION OF MORTALITY IN ADVANCED CKD USING TROPONIN T
Chesnaye N; Szummer K; Barany P; Heimburger O; Stenvinkel P; Melander S; Dekker FW; Wanner C; Jager K; Evans M
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
SODIUM POLYSTYRENE SULFONATE, PRACTICE PATTERNS AND ASSOCIATED ADVERSE EVENT RISK; A NATIONWIDE ANALYSIS FROM THE SWEDISH RENAL REGISTER
Laureati P; Evans M; Trevisan M; Schalin L; Bellocco R; Sood MM; Barany P; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
PENTOSIDINE IN END-STAGE RENAL DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) VERSUS OTHER ETIOLOGIES
Jankowska M; Qureshi AR; Lu D; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34:165
PREDICTORS OF VASCULAR CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS
Dai L; Debowska M; Lukaszuk T; Bobrowski L; Pietribiasi M; Barany P; Soderberg M; Wernerson A; Lindholm B; Qureshi AR; Waniewski J; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34
56th Congress of the European Renal Association (ERA) & European Dialysis and Transplant Association (EDTA) Budapest, Hungary June 13-16, 2019 Abstracts
Iseri K; Qureshi AR; Dai L; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Corrigendum: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21(4):540
'Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists' (vol 20, pg 1217, 2018)
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund LH; Carrero JJ
Conference publication: PEDIATRIC NEPHROLOGY. 2018;33(10):1836
AKI IN INFANTS WITH HYPOTHERMIA-TREATED HYPOXIC-ISCHAEMIC ENCEPHALOPATHY
Grossmann KR; Chromek M; Barany P; Blennow M
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
HIGH FIBRINOGEN LEVELS ARE INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
Hasbal NB; Mukai H; Chen Z; Lindholm B; Rger OH; Barany P; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33:444
HIGHER MEAN CORPUSCULAR VOLUME ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Lindholm B; Heimburger O; Barany P; Qureshi AR; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
HIGHER NEUTROPHIL TO LYMPHOCYTE RATIO ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS
Mukai H; Kato S; Lindholm B; Heimburger O; Barany P; Washida N; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
PLASMA POTASSIUM AND THE RISK OF MORTALITY: A TIME-DEPENDENT ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Trevisan M; Evans M; Xu H; Lindholm B; Barany P; Elinder C-G; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
EGFR AND THE RISK OF CANCER: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Xu H; Su G; Trevisan M; Elinder C-G; Barany P; Lindholm B; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
FIBROBLAST GROWTH FACTOR 23 IS ASSOCIATED WITH FRACTIONAL SODIUM EXCRETION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Xu H; Hashem A; Witasp A; Mencke R; Stenvinkel P; Barany P; Bruchfeld A; Wernerson A; Carrero J-J; Olauson H
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018;33
INCIDENCE, PREDICTORS AND CLINICAL MANAGEMENT OF HYPERKALEMIA IN NEW USERS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS
Trevisan M; de Deco P; Xu H; Evans M; Lindholm B; Bellocco R; Barany P; Jernberg T; Lund L; Carrero JJ
Conference publication: CIRCULATION. 2017;136
Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Mok Y; Ballew S; Grams M; Coresh J; Carrero J-J; Evans M; Barany P; Matsushita K
Conference publication: PEDIATRIC NEPHROLOGY. 2017;32(9):1659-1660
THE FGF23 AND KLOTHO AXIS IN PEDIATRIC CHRONIC KIDNEY DISEASE - A PROSPECTIVE COHORT STUDY
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Barany P
Meeting abstract: ATHEROSCLEROSIS. 2017;263:e274
PLASMA LIPOPROTEINS IN CHRONIC KIDNEY DISEASE: INCREASED BINDING TO ARTERIAL PROTEOGLYCANS PREDICTS CARDIOVASCULAR MORTALITY
Matteo P; Peter S; Minniti ME; Emma K; Arne D; Sanam E; Monica G; Peter B; Rashid QA; German C; Bengt L; Katariina O; Uwe T; Laura C; Eva H-C; Paolo P
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:974
Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease
Szummer K; Trevisan M; Barany P; Xu H; Evans M; Carrero JJ
Review: BMJ OPEN. 2017;7(4):e014345
High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines
Eriksen J; Gustafsson LL; Ateva K; Bastholm-Rahmner P; Ovesjo M-L; Jirlow M; Juhasz-Haverinen M; Larfars G; Malmstrom RE; Wettermark B; Andersen-Karlsson E
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
OBSTRUCTIVE AND RESTRICTIVE LUNG FUNCTION ASSOCIATES WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Mukai H; Ming P; Lindholm B; Rger OHSD; Barany P; Stenvinkel P; Qureshi A
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32:173
CAUSES OF DEATH ACROSS REDUCED KIDNEY FUNCTION; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Runesson B; Qureshi A; Gasparini A; Barany P; Evans M; Elinder C-G; Wettermark B; Carrero J-J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
COMBINATION OF GENOTYPE AND PHENOTYPE FEATURES AS PREDICTORS OF INFLAMMATION, CARDIOVASCULAR DISEASE AND PROTEIN ENERGY WASTING IN PATIENTS WITH CHRONIC KIDNEY DISEASES
Debowska M; Lukaszuk T; Nordfors L; Carrero JJ; Qureshi AR; Stenvinkel P; Heimburger O; Barany P; Bobrowski L; Schalling M; Lindholm B; Waniewski J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
IMPACT OF CINACALCET TREATMENT ON CARDIOVASCULAR OUTCOMES IN CKD PATIENTS WITH SECONDARY HYPERPARATHYROIDISM; THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Evans M; Methven S; Sjolander A; May M; MacNeill S; Birnie K; Barany P; Carrero J-J; Caskey F
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32:13
INAPPROPRIATE PRESCRIPTION OF NEPHROTOXIC DRUGS TO INDIVIDUALS WITH CHRONIC KIDNEY DISEASE: A COMMUNITY-BASED ANALYSIS FROM THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT
Gasparini A; Wettermark B; Schmidt-Mende K; Evans M; Qureshi AR; Barany P; Elinder C-G; Carrero J-J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
KIDNEY FUNCTION AND THE RISK OF COMMUNITY ACQUIRED INFECTIONS
Xu H; Gasparini A; Ishigami J; Mzayen K; Su G; Barany P; Arnlov J; Lindholm B; Elinder CG; Matsushita K; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL STATUS AS PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Mukai H; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi A
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
INFLAMMATION MODIFIES THE MORTALITY PREDICTIVE CAPACITY OF OXIDATIVE DNA DAMAGE IN CHRONIC KIDNEY DISEASE PATIENTS
Dai L; Qureshi A; Mukai H; Machowska A; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32
CIRCULATING PROTEINS AS PREDICTORS OF CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS - A PROTEOMIC APPROACH
Feldreich T; Fall T; Carlsson A; Jesus-Carrero J; Qureshi A; Heimburger O; Barany P; Stenvinkel P; Arnlov J
Meeting abstract: ATHEROSCLEROSIS. 2016;252:E237
WORKSHOP 2.1: LIPOPROTEINS AND EXTRACELLULAR MATRIX. INCREASED LIPOPROTEIN BINDING TO ARTERIAL PROTEOGLYCANS AND NORMAL MACROPHAGE CHOLESTEROL EFFLUX CAPACITY DEFINE THE PRO-ATHEROGENIC FEATURE OF CKD DYSLIPIDEMIA
Pedrelli M; Stenvinkel P; Minniti ME; Emma K; Dikkers A; Ebtehaj S; Gomaraschi M; Barany P; Qureshi AR; Camejo G; Lindholm B; Oorni K; Tietge U; Calabresi L; Hurt-Camejo E; Parini P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1584-1585
BONE MINERAL DENSITY IN LIVING DONOR RENAL TRANSPLANTATION RECIPENTS ASSOCIATES WITH FIBROBLAST GROWTH FACTOR23
Chen Z; Haarhaus M; Olauson H; Barany P; Wennberg L; Ripsweden J; Brismar T; Bergstrom I; Lindholm B; Stenvinkel P; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1467
LOW BONE MINERAL DENSITY OF LEGS AND FEMORAL NECK ASSOCIATES WITH CORONARY CALCIFICATION SCORE IN FEMALE END-STAGE RENALDISEASE PATIENTS
Chen Z; Qureshi AR; Haarhaus M; Olauson H; Heimburger O; Barany P; Ripsweden J; Brismar T; Bergstrom I; Lindholm B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:334
THE FGF23 AND KLOTHO AXIS IN PEDIATRIC CKD - A PROSPECTIVE COHORT STUDY
Lindblad YT; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:208
PULMONARY DYSFUNCTION IS LINKED TO MALNUTRITION AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS
Pei M; Mukai H; Barany P; Chen Z; Heimburger O; Lindholm B; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:183-184
PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION
Van Craenenbroeck A; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Heimburger O; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:167
GLOMERULAR FILTRATION RATE ESTIMATION USING BETA TRACE PROTEIN: EXTERNAL VALIDATION OF THREE EQUATIONS
Van Craenenbroeck AH; Qureshi AR; Bragfors-Helin A-C; Simonsson P; Lindholm B; Barany P; Anderstam B; Stenvinkel P; Heimburger O
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:92-93
IS END-STAGE POLYCYSTIC KIDNEY DISEASE ASSOCIATED WITH IMPAIRMENT OF GLUCOSE METABOLISM?
Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i584-i585
MP738BONE MINERAL DENSITY IN LIVING DONOR RENAL TRANSPLANTATION RECIPENTS ASSOCIATES WITH FIBROBLAST GROWTH FACTOR23
Chen Z; Haarhaus M; Olauson H; Barany P; Wennberg L; Ripsweden J; Brismar T; Bergström I; Lindholm B; Stenvinkel P; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1449
LOWER CALCIUM IS ASSOCIATED WITH KIDNEY FUNCTION DECLINE IN INDIVIDUALS WITH CHRONICKIDNEY DISEASE
Janmaat CJ; van Diepen M; Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Elinder CG; Rotmans JI; Vervloet M; Dekker FW; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:191-192
PREVALENCE, DIAGNOSIS AND NEPHROLOGY CARE OF CKD IN THE REGION OF STOCKHOLM
Gasparini A; Evans M; Qureshi AR; Arnlov J; Barany P; Coresh J; Wettermark B; Elinder C-G; Carrero J-J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:1516
SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS
Mukai H; Svedberg O; Chen Z; Lindholm B; Eriksson M; Bragfors-Helin A-C; Heimburger O; Barany P; Qureshi AR; Anderstam B; Stenvinkel P
Review: KIDNEY INTERNATIONAL. 2016;89(1):28-39
Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Macdougall IC; Bircher AJ; Eckardt K-U; Obrador GT; Pollock CA; Stenvinkel P; Swinkels DW; Wanner C; Weiss G; Chertow GM
Meeting abstract: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii669
A LONGITUDINAL STUDY OF CARDIOVASCULAR FUNCTION IN PEDIATRIC CHRONIC KIDNEY DISEASE AND POST-TRANSPLANT PATIENTS AS ASSESSED BY TISSUE AND PULSE WAVE DOPPLER ECHOCARDIOGRAPHY
Lindblad YT; Herthelius M; Axelsson J; Vavilis G; Balzano R; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30
HIGH SENSITIVE TROPONIN T AND TROPONIN I THREE MONTH VARIATION IN PREVALENT HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Snaedal S; Barany P; Qureshi AR; Heimburger O; Stenvinkel P; Lowbeer C; Szummer K
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii519-iii520
CIRCULATING PLASMA PENTOSIDINE IN PRE-DIALYSIS, PRE-TRANSPLANT, PERITONEAL DIALYSIS (PD) AND HEMODIALYSIS (HD) PATIENTS (PTS)
Machowska A; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii261
ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS
Isoyama N; Machowska A; Qureshi AR; Yamamoto T; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Bengt L
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30:iii267
MUSCLE STRENGTH, MUSCLE MASS AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS
Xu H; Cabezas-Rodriguez I; Qureshi AR; Heimburger O; Barany P; Cannata-Andia J; Lindholm B; Stenvinkel P; Carrero JJ
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:154
High sensitive troponin T and I levels and variation over three months in prevalent hemodialysis patients
Snaedal S; Barany P; Qureshi AR; Heimburger O; Stenvinkel P; Lowbeer C; Szummer K
Review: LAKARTIDNINGEN. 2014;111(27-28):1176-1179
[Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease].
Stenvinkel P; Irving GF; Wegener S; Eyre S; Rippe B; Segelmark M; Barany P; Samuelsson O
Review: DRUGS & AGING. 2014;31(7):493-499
The Use of Estimated Glomerular Filtration Rate for Dose Adjustment of Medications in the Elderly
Elinder C-G; Barany P; Heimburger O
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:411
ARTERIAL STIFFNESS AND SKIN AUTOFLUORESCENCE IN END-STAGE RENAL DISEASE (ESRD) PATIENTS
Svedberg O; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Leurs P; Isoyama N; Lindholm B; Anderstam B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:407
CIRCULATING S100A12 (EN-RAGE), SOLUBLE RAGE, AND MORTALITY IN CHRONIC KIDNEY DISEASE STAGE 5 PATIENTS
Isoyama N; Leurs P; Qureshi AR; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:410
THYROID HORMONES ASSOCIATE WITH PENTOSIDINE IN HEMODIALYSIS (HD) PATIENTS
Leurs P; Meuwese C; Carrero JJ; Qureshi AR; Anderstam B; Barany P; Heimburger O; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:413
INCREASED LEVELS AND VARIATION OF IL6 IN HEMODIALYSIS VERSUS PERITONEAL DIALYSIS PATIENTS
Snaedal S; Qureshi AR; Carrero JJ; Heimburger O; Stenvinkel P; Barany P
Other: NATURE REVIEWS NEPHROLOGY. 2013;9(12):707-708
CHRONIC KIDNEY DISEASE Obesity in children with end-stage renal disease
Krmar RT; Barany P
Conference publication: THERAPEUTIC DRUG MONITORING. 2013;35(5):667-668
Systematic Conversion to Generic Tacrolimus in Stable Kidney Transplant Patients
Rosenborg S; Nordstrom A; Almquist T; Wennberg L; Barany P
Letter: LAKARTIDNINGEN. 2013;110(34-35):1481-1483
[Treatment with cinacalcet in secondary hyperparathyroidism for dialysis patients: The will is good--but what about the evidence?].
Bárány P; Elinder C-G; Samuelsson O
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:243
DELTA-HE - A NOVEL MARKER OF ERYTHROPOIESIS AND INFLAMMATION - PREDICTS MORTALITY IN PERITONEAL DIALYSIS (PD) PATIENTS
Danielson K; Qureshi AR; Heimburger O; Stenvinkel P; Lindholm B; Hylander-Rossner B; Germanis G; Hansson M; Beshara S; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:35
NON-THYROIDAL ILLNESS - A NOVEL RISK FACTOR FOR CORONARY CALCIFICATION AND ARTERIAL STIFFNESS IN DIALYSIS PATIENTS?
Meuwese CL; Carrero JJ; Cabezas-Rodriguez I; Heimburger O; Barany P; Lindholm B; Qureshi AR; Ripsweden J; Dekker FW; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013;28:217
PREDICTING ARTERIAL STIFFNESS USING SKIN AUTOFLUORESCENCE IN PERITONEAL DIALYSIS PATIENTS
Svedberg O; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Leurs P; Anderstam B
Letter: JOURNAL OF NEUROSURGERY. 2013;118(4):908-912
Barany and traumatic brain injury
Barany P
Conference publication: PEDIATRIC NEPHROLOGY. 2012;27(9):1724
EARLY DETECTION OF LEFT VENTRICULAR DYSFUNCTION BY TISSUE DOPPLER ECHOCARDIOGRAPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASE
Lindblad YT; Axelsson J; Balzano R; Vavilis G; Celsi G; Chromek M; Barany P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27:410
INSULIN GROWTH FACTOR-1 (IGF-1) AS A PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN CHRONIC KIDNEY DISEASE (CKD) STAGE 5 PATIENTS
Jia T; Axelsson TG; Lindholm B; Heimburger O; Barany P; Stenvinkel P; Qureshi AR
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27:287
ESSENTIAL POLYUNSATURATED FATTY ACIDS, INFLAMMATION AND MORTALITY IN DIALYSIS PATIENTS
Huang X; Stenvinkel P; Qureshi AR; Riserus U; Cederholm T; Barany P; Heimburger O; Lindholm B; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27:272
ESTIMATED HEPATIC AND ADIPOSE TISSUE STEAROYL-COA DESATURASE-1 ACTIVITIES ARE ASSOCIATED WITH INFLAMMATION AND ALL-CAUSE MORTALITY IN DIALYSIS PATIENTS
Huang X; Stenvinkel P; Qureshi AR; Riserus U; Cederholm T; Barany P; Heimburger O; Lindholm B; Carrero JJ
Letter: CLINICAL NEPHROLOGY. 2012;77(1):85-86
Screening for anti-factor B autoantibody in a patient with acute renal injury due to dense deposit disease
Krmar RT; Skattum L; Barany P; Jozsi M
Published conference paper: CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY. 2012;178:35-39
Hypogonadism in Males with Chronic Kidney Disease: Another Cause of Resistance to Erythropoiesis-Stimulating Agents?
Stenvinkel P; Barany P
Editorial: NATURE REVIEWS NEPHROLOGY. 2011;8(2):72-74
DIALYSIS IN 2011 Can cardiovascular risk in dialysis patients be decreased?
Stenvinkel P; Barany P
Conference publication: APMIS. 2009;117:143
Target for time to treatment initiation may improve management of patients with ANCA-associated vasculitis (AAV)
Barany P; Wendt M; Bruchfeld A
Conference publication: BLOOD PURIFICATION. 2009;28(4):318
Elevated Visfatin/NAMPT Correlates with Anorexia and Reduced Fasting Serum Amino Acids in CKD Patients
Jesus CJ; Witasp A; Lindholm B; Nordfors L; Schalling M; Axelsson J; Stenvinkel P; Qureshi AR; Heimburger O; Barany P; Suliman ME; Anderstam B
Conference publication: BLOOD PURIFICATION. 2008;26(5):436-437
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero JJ; Axelsson J; Heimburger O; Barany P; Lindholm B; Stenvinkel P; Qureshi AR
Conference publication: BLOOD PURIFICATION. 2008;26(5):435
Endogenous testosterone and mortality due to all-causes and cardiovascular disease in men undergoing hemodialysis
Carrero JJ; Qureshi AR; Parini P; Arver S; Lindholm B; Barany P; Heimburger O; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:311
Association between tumor necrosis factor alpha (TNF) gene polymorphism and cardiovascular mortality in end-stage renal disease patients
Kato S; Axelsson J; Qureshi AR; Yusawa Y; Maruyama Y; Barany P; Heimburger O; Schalling M; Stenvinkel P; Lindholm B; Nordfors L
Conference publication: BLOOD PURIFICATION. 2007;25(4):355
Is α2-Heremans-Schmid glycoprotein/fetuin-A associated with aspects of the metabolic syndrome in patients with chronic kidney disease (CKD)?
Axelsson J; Ketteler M; Heimburger O; Barany P; Lindholm B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:141
S-adenosylhomocysteine levels are elevated and associated with cardiovascular disease in chronic kidney disease patients
Valli A; Carrero JJ; Suliman ME; Qureshi AR; Garibotto G; Barany P; Anderstam B; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:140-141
Serum long pentraxin 3 (PTX3) levels predict death in chronic kidney disease (CKD) patients independently of CRP values
Tong M; Carrero JJ; Suliman M; Qureshi AR; Anderstam B; Axelsson J; Heimburger O; Barany P; Stenvinkel P; Alvestrand A; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:74-75
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in CKD stage 5 patients
Carrero JJ; Qureshi AR; Axelsson J; Barany P; Heimburger O; Alvestrand A; Lindholm B; Stenvinkel P
Conference publication: BLOOD PURIFICATION. 2007;25(4):338
Telomere shortening, a new mortality risk factor in dialysis patients.: Associations with inflammatory markers and fetuin-a levels
Carrero JJ; Stenvinkel P; Fellstrom B; Qureshi AR; Lamb K; Heimbuerger O; Barany P; Radhakrishnan K; Lindholm B; Sovery I; Nordfors L; Shiels PG
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21:408
The osteoclast inhibitor osteoprotegerin is an independent predictor of survival in end-stage renal disease patients starting dialysis
Matsubara K; Anderstam B; Suliman M; Qureshi AR; Axelsson J; Martola L; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21:127
Toll like receptor 4 (TLR4) and tumor necrosis factor(TNF)-α genotypes influence mortality in end-stage renal disease (ESRD) patients
Kato S; Nordfors L; Axelsson J; Qureshi AR; Yuzawa Y; Maruyama Y; Barany P; Heimburger O; Schalling M; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21:441
C-reactive protein variation and comorbidity in prevalent hemodialysis patients
Jonsdottir SS; Barany P; Heimburger O; Qureshi AR; Danielsson A; Fellstrom B; Wikstrom B; Seeberger A; Alvestrand A; Stenvinkel P
Letter: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;47(2):372
Serum leptin and epoetin sensitivity -: Reply
Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
Conference publication: BLOOD PURIFICATION. 2006;24(5-6):479
Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 Exon 8 insertion/deletion polymorphism
Axelsson J; Wang X; Nordfors L; Qureshi AR; Avesani C; Barany P; Schalling M; Stenvinkel P; Heimbuerger O; Lindholm B
Review: SEMINARS IN NEPHROLOGY. 2006;26(1):14-19
Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients
Suliman ME; Stenvinkel P; Bárány P; Qureshi AR; Lindholm B
Letter: KIDNEY INTERNATIONAL. 2005;68(6):2916
Serum fetuin-A and aortic calcification in hemodialysis patients -: Reply from the authors
Axelsson J; Bárány P; Heimbürger O; Lindholm B; Nordfors L; Stenvinkel P
Editorial: NATURE CLINICAL PRACTICE NEPHROLOGY. 2005;1(1):12-13
Is the efficacy of epoetin beta in anemic peritoneal dialysis patients maintained with fortnightly doses? Commentary
Bárány P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V312
The ACE intron 16 del/del genotype is associated with mortality and inflammation in ESRD patients
Watanabe M; Nordfors L; Axelsson J; Barany P; Heimbürger O; Qureshi AR; Suliman M; Schalling M; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V309
Insulin resistance and dyslipidemia in end-stage renal disease (ESRD) patients are influenced by the interleukin-18-137 G to C polymorphism
Honda H; Nordfors L; Qureshi AR; Axelsson J; Schalling M; Sugisaki T; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V137
Association between change in body composition and insertion/deletion polymorphism of uncoupling protein 2 in dialysis patients
Wang X; Stenvinkel P; Nordfors L; Heimbürger O; Barany P; Qureshi AR; Axelsson J; Schalling M; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V130
Oxidative stress is associated with the insertion/deletion polymorphism in exon 8 of the uncoupling protein 2 gene in ESRD patients
Wang X; Stenvinkel P; Nordfors L; Axelsson J; Qureshi AR; Barany P; Schalling M; Diczfalusy U; Heimbürger O; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V99
Bone mineral density is a predictor of survival in ESRD patients
Matsubara K; Suliman ME; Qureshi ART; Axelsson J; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V84
Factors associated with bone mineral density in CKD patients
Matsubara K; Suliman ME; Qureshi ART; Axelsson J; Anderstam B; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V83-V84
Plasma glutamate is related to the bone status in CKD patients
Suliman ME; Qureshi ART; Anderstam B; Matsubara K; Axelsson J; Divino JC; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V78
Association between estrogen receptor alpha (ESRA) gene polymorphism and mortality in end-stage renal disease (ESRD) patients starting dialysis therapy
Kato S; Nordfors L; Stenvinkel P; Heimbürger O; Qureshi AR; Axelsson J; Barany P; Schalling M; Lindholm B
Conference publication: NEPHROLOGY. 2005;10:A289
A FUNCTIONAL POLYMORPHISM IN THE PROMOTER REGION OF THE GENE ENCODING FOR INTERLEUKIN-6 (IL-6) IS ASSOCIATED WITH INCREASED PLASMA LEVELS OF HIGH DENSITY LIPOPROTEIN (HDL) IN PATIENTS WITH END-STAGE RENAL DISEASE (ESRD)
Axelsson J; Heimburger O; Barany P; Lindholm B; Nordfros L; Stenvinkel P
Editorial: BLOOD PURIFICATION. 2005;23(3):203-210
Why do dialysis patients develop a heart of stone and bone of china?
Martola L; Barany P; Stenvinkel P
Editorial: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20(1):16-21
Homocysteine in uraemia - a puzzling and conflicting story
Suliman ME; Bárány P; Kalantar-Zadeh K; Lindholm B; Stenvinkel P
Review: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19:1-47
Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure
Locatelli F; Aljama PA; Bárány P; Canaud B; Carrera F; Eckardt KU; Hörl WH; Macdougall IC; Macleod A; Wiecek A; Cameron S
Editorial: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19(2):288-293
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: where are we now and where do we go from here?
Locatelli F; Aljama P; Barany P; Canaud B; Carrera F; Eckardt KU; Macdougall IC; Macleod A; Hörl WH; Wiecek A; Cameron S
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:676A-677A
Change in common carotid intima media thickness (CC IMT), in first year of dialysis therapy, is related to plasma pentosidine content.
Suliman ME; Stenvinkel P; Jogestrand T; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:536A
Associations between circulating inflammatory markers and renal function in elderly subjects.
Pecoits R; Heimburger O; Stenvinkel P; Barany P; Suliman M; Lindholm B; Fehrman-Ekholm I
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:532A
Plasma total homocysteine (tHcy) is related to plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).
Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:292A
Single nucleotide polymorphisms (SNPs) in genes coding for C-reactive protein (CRP) and interleukin-6 (IL-6) and clinical consequences of inflammation in chronic renal failure (CRF)
Heimburger O; Marchlewska A; Pecoits-Filho R; Lindholm B; Barany P; Jonsson E; Hoff CM; Schalling M; Stenvinkel P; Nordfors L
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:195A
Higher plasma total homocysteine (tHcy) level is associated with better survival in patients (pts) with end-stage renal disease (ESRD)
Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:194A
Plasma total homocysteine (tHcy) is low in inflamed end-stage renal disease (ESRD) patients (pts)
Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:529A
Chronic inflammation independently reduces plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).
Suliman ME; Pecoits R; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Ayala ER; Divino JC; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:530A
Relationship between circulating levels of interleukin-6 (IL-6) and fat mass in patients (pts) with end-stage renal disease (ESRD).
Suliman ME; Axelsson J; Heimburger O; Quershi AR; Barany P; Pecoits R; Lindholm B; Stenvinkel P
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:531A
Plasma adiponectin and its relations to albuminuria, type of diabetes, body composition, inflammation and genetic variations in the gene encoding adiponectin in ESRD.
Stenvinkel P; Marchlewska A; Pecoits R; Heimburger O; Hoff C; Holmes C; Axelsson J; Barany P; Lindholm B; Nordfors L
Published conference paper: KIDNEY INTERNATIONAL, SUPPLEMENT. 2003;63(84):S172-S176
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients
Pecoits R; Stenvinkel P; Marchlewska A; Heimburger O; Bárány P; Hoff CM; Holmes CJ; Suliman M; Lindholm B; Schalling M; Nordfors L
Published conference paper: AMERICAN JOURNAL OF KIDNEY DISEASES. 2003;41(3):S89-S95
Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus
Suliman ME; Stenvinkel P; Bárányi P; Heimbürger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:760A
Relationship between changes in plasma total homocysteine (tHcy) and serum albumin following renal replacement therapy (RRT).
Suliman ME; Stenvinkel P; Barany P; Heimburger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:519A-520A
Genetic variation in the gene encoding adiponectin is associated with cardiovascular disease (CVD) and inflammation in end stage renal disease (ESRD) patients
Pecoits R; Stenvinkel P; Marchlewska A; Nordfors L; Heimburger O; Hoff C; Barany P; Lindholm B; Schalling M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:519A
A functional variant in the myeloperoxidase (MPO) gene is associated with cardiovascular disease in end stage renal disease (ESRD) patients
Pecoits R; Marchlewska A; Nordfors L; Heimburger O; Barany P; Hoff C; Stenvinkel P; Lindholm B; Schalling M
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:466A-467A
No association between plasma total homocysteine (tHcy) and common carotid intima thickness (CC IMT) in end-stage renal disease (ESRD) patients (pts)
Suliman ME; Stenvinkel P; Barany P; Heimburger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:222A
Impaired respiratory function is associated with malnutrition and inflammation in ESRD patients
Barany P; Pecoits R; Lindholm B; Heimburger O; Stenvinkel P
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:594A
Plasma pentosidine is associated with inflammation but does not predict outcome in renal replacement therapy
Stenvinkel P; Suliman M; Olof H; Barany P; Pecoits R; Lindholm B
Published conference paper: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17:32-37
Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure:: links to inflammation and oxidative stress
Stenvinkel P; Bárány P
Published conference paper: KIDNEY INTERNATIONAL, SUPPLEMENT. 2002;61(80):103-108
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?
Stenvinkel P; Barany P; Heimbürger O; Pecoits R; Lindholm B
Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(3):528
Accumulation of taurine in patients with renal failure
Suliman ME; Bárány P; Divino JC; Lindholm B; Bergström J
Published conference paper: KIDNEY INTERNATIONAL. 2000;57(4):1727-1735
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Divino JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2000;72(3):299-300
Physical activity promotes health also among dialysis patients
Stenvinkel P; Elinder CG; Bárány P
Letter: KIDNEY INTERNATIONAL. 1998;53(5):1430-1431
Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure?
Stenvinkel P; Heimbürger O; Lönnqvist F; Bárány P
Book chapter: CRITICAL CARE NEPHROLOGY. 1998;p. 375-389
Nutritional management of the critically ill patient with and without renal failure
Bárány P; Alvestrand A
Published conference paper: MINERAL AND ELECTROLYTE METABOLISM. 1997;23(3-6):273-276
Serum ferritin and tissue iron in anemic dialysis patients
Barany P; Eriksson LC; Hultcrantz R; Pettersson E; Bergstrom J
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1996;7(9):A1117
Physiological effects of correcting anemia in hemodialysis patients (HD pts) to a normal HB
Barany P; Svedenhag J; Katzarski K; Divino J; Norman R; Freyschuss U; Bergstrom J
Review: PERITONEAL DIALYSIS INTERNATIONAL. 1996;16 Suppl 1:S260-S266
Endocrinology and PD: optimal treatment of anemia in peritoneal dialysis patients.
Bárány P
Conference publication: JOURNAL OF CHEMOTHERAPY. 1993;5:605-606
CLOSTRIDIUM-DIFFICILE INFECTION IS A POOR PROGNOSTIC SIGN IN UREMIC PATIENTS
BARANY P; STENVINKEL P; BERGSTROM J; NORD CE
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):504
LONGITUDINAL-STUDY OF LIFE QUALITY (QL) IN HEMODIALYSIS (HD) PATIENTS TREATED WITH ERYTHROPOIETIN (EPO)
BARANY P; PETTERSSON E
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):504
LOW-DOSE SUBCUTANEOUS RHUEPO IN RENAL ANEMIA IN CAPD CCPD PATIENTS - INTERIM ANALYSIS OF A SWEDISH MULTICENTER STUDY
BARANY P; CLYNE N; HYLANDER B; JOHANSSON AC; SIMONSEN O; MAGNUSSON M; FRISENETTEFICH C
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):505
LYMPHOCYTOTOXIC ANTIBODIES AND IMMUNE REACTIVITY INVITRO IN EPO (ERYTHROPOIETIN) TREATED HEMODIALYSIS-PATIENTS
FEHRMAN I; BARANY P; LINDHOLM A
Conference publication: KIDNEY INTERNATIONAL. 1992;41(2):503
CLOSTRIDIUM-DIFFICILE INFECTION (CDI) - A POOR PROGNOSTIC SIGN IN UREMIC PATIENTS
STENVINKEL P; BARANY P; NORD CE; BERGSTROM J
Conference publication: KIDNEY INTERNATIONAL. 1990;37(5):1383
PHYSIOLOGIC EFFECTS OF ERYTHROPOIETIN (EPO) TREATMENT IN ANEMIC HEMODIALYSIS (HD) PATIENTS AT REST AND EXERCISE
BARANY P; FREYSCHUSS U; PETTERSSON E; BERGSTROM J
Show more

Employments

Clinical Position (hourly employee), Renal Medicine, Renal Medicine, Karolinska University Hospital, 2024-
Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2024-2027
Clinical Position, ME Högspecialiserad barnmedicin och hemsjukvård, Karolinska Universitetssjukhuset

Articles

All other publications

Employments

Degrees and Education

Supervision

0

1

2

3

4

5

Editorial work

News from KI

Events from KI